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Abstract 
 
Vision impairment and blindness are in industrialized countries primarily caused by the 
degeneration of the retina, the light sensing tissue inside the eye. The degeneration, occurring 
in diseases like age-related macular degeneration (AMD) or retinitis pigmentosa (RP), can be 
caused by environmental factors as well as genetic defects and thus shows diverse pathologies. 
In all conditions, the light detecting photoreceptors (rods and/or cones) are dying caused by 
either direct photoreceptor damage or as a secondary effect following degeneration of 
supporting cells. 
Although promising treatment approaches are currently under investigation, up to date it is not 
possible to cure these diseases. Amongst these therapeutic strategies, pre-clinical studies 
evaluating the replacement of degenerated cells by transplantation of new photoreceptors 
demonstrated promising results. First studies conducted the specific enrichment and 
transplantation of primary photoreceptors derived from postnatal mice and their sufficient 
integration and differentiation into mature photoreceptors in wild-type as well as degenerated 
mouse retinae. Recent experiments additionally proved the recovery of some dim-light vision 
after transplantation in mice lacking night sight. The in vitro differentiation of whole eye cups 
containing photoreceptors, out of human or mouse ES or iPS cells, peaked in the 
transplantation of ES-derived photoreceptors into wild-type as well as degenerated mice and the 
integration and maturation of these cells. These observations are encouraging, but prior to a 
save implementation of this strategy into a clinical routine, several further hurdles need to be 
challenged. 
 
Collection of photoreceptors out of whole retinal tissues prior to transplantation was shown to be 
an important step to reach high integration rates. Additionally, transplantation of photoreceptors 
derived from stem cells comprises the risk of tumor formation after transplantation and thus also 
requires depletion of inadvertent cells. Therefore, we established the enrichment of 
photoreceptors using the cell surface marker dependent method magnetic-activated cell sorting 
(MACS). For identification of suitable target-specific surface markers, we characterized young 
transplantable mouse photoreceptors using microarray analysis and screened their 
transcriptome. Amongst others, ecto-5´nucleotidase (Nt5e, termed CD73) was identified being a 
rod photoreceptor specific cell surface protein. Thus, we enriched young photoreceptors with 
CD73-dependent MACS with sufficient purity and transplanted these cells into the subretinal 
space of wild-type mice. In contrast to unsorted retinal cells, enriched photoreceptors integrated 
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in significantly higher number into the host retina, proving that MACS is a suitable alternative for 
specific photoreceptor enrichment. Testing other proteins, identified as photoreceptor specific, 
for MACS suitability and the translation of this approach to photoreceptors, derived from mouse 
as well as human iPS or ES cells, should be the focus of consecutive investigations. 
The integration of grafted cells into the retina is a complex process dependent on a variety of 
influencing factors. Transplantation experiments in aging wild-type mice and a rod-depleted 
mouse model, containing a retina composed of cone and cone-like photoreceptors, indicated 
that the activation of Müller glia cells facilitates integration of transplanted photoreceptors. 
Besides that, reduced outer limiting membrane (OLM) integrity, increased subretinal graft 
distribution or reduced retinal cell density are further suggested as potential cell engraftment 
enhancers. These factors might open up important possibilities of host retina manipulation to 
increase cell integration rates. 
Although retinal transplantation experiments were in addition to mice also performed using pigs 
or rats as hosts, the transplantation of enriched single photoreceptors, following the protocols 
successfully established in mice, has not been performed in other species. Nevertheless, 
transferring this technique is important and would allow better predictions for future application 
in human patients. Therefore, we transferred our protocol, using CD73 based MACS, to the rat 
and successfully enriched rat photoreceptors with sufficient purity. We subsequently 
transplanted these cells into the subretinal space of rats as well as mice and observed limited 
integration capacity of grafted cells. Only few transplanted rat photoreceptors were localized in 
the rat retina, lacking proper photoreceptor morphology. Especially regarding a perspective 
clinical application in humans, these data are remarkable. They imply the question, whether low 
integration in rat represents a general problem and might thus also be relevant for treatment in 
humans, or whether the rat retina forms just an exception.  
Thus, further detailed analysis of the cellular and molecular mechanisms underlying the 
integration process of transplanted photoreceptors represent an essential prerequisite for the 
development of a safe and efficient therapy, aiming to treat retinal degenerative diseases 
characterized by photoreceptor loss. 
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Zusammenfassung 
 
Degenerationserkrankungen der Netzhaut (Retina) sind in Industrieländern die Hauptursache 
für verminderte Sehfähigkeit und Blindheit. Sowohl Umweltfaktoren als auch vererbte 
Mutationen können Defekte wie altersbedingte Makuladegeneration (AMD) oder Retinitis 
pigmentosa (RP) auslösen und führen zu einem sehr variablen Krankheitsbild. Eine 
Gemeinsamkeit aller Formen ist das Absterben der lichtdetektierenden Fotorezeptoren 
(Stäbchen und/oder Zapfen). Dieses kann entweder durch direkte Schädigung, oder als 
Sekundäreffekt nach Degeneration der unterstützenden Zellen erfolgen. 
Obwohl im Moment vielversprechende Behandlungsansätze untersucht werden, ist es zurzeit 
nicht möglich, retinale Degenerationserkrankungen dieser Art zu heilen. Ein 
erfolgversprechender Ansatz könnte jedoch der Ersatz der degenerierten Zellen durch 
transplantierte Fotorezeptoren sein. Erste Studien demonstrierten die spezifische Anreicherung 
von primären Fotorezeptoren aus der Netzhaut neugeborener Mäuse und deren subretinale 
Transplantation in Wildtyp-Mäuse und Mausmodelle mit retinaler Degeneration. Die 
transplantierten Zellen integrierten in die Empfängernetzhaut und entwickelten sich in 
ausgereifte Fotorezeptoren und konnten unter anderem bei nachtblinden Mäusen die 
Sehfähigkeit bei Dunkelheit verbessern. Die Differenzierung von humanen oder murinen ES- 
und iPS-Zellen in vitro in vollständige Retinae und die Transplantation daraus gewonnener 
Fotorezeptoren in Mäuse, bilden vorläufig den Höhepunkt dieser Entwicklung. Obwohl die 
Fortschritte der jüngsten Vergangenheit beeindruckend sind, sollten vor der sicheren und 
effektiven Anwendung einer retinalen Zellersatztherapie als therapeutische Maßnahme beim 
Menschen noch einige wissenschaftliche Fragestellungen beantwortet werden. 
Studien zeigen, dass Zellpopulationen, die direkt aus der Spendernetzhaut entnommen und 
transplantiert wurden, auf Grund ihrer Heterogenität in geringeren Zahlen in die 
Empfängerretina einwandern als angereicherte Fotorezeptoren. Zusätzlich besteht bei 
unsortierten Zellen, die aus Stammzellpopulationen gewonnen wurden, das Risiko einer 
Tumorbildung. Daher haben wir die magnetisch-aktivierte Zellsortierung (MACS) zur 
Anreicherung junger Fotorezeptoren etabliert. Die dabei benötigten, für Fotorezeptoren 
spezifischen, Oberflächenproteine wurden mit Hilfe von Microarray-Analysen des Transkriptoms 
junger Stäbchen von Mäusen identifiziert. Dabei wurde unter anderem die 5'-Nukleotidase 
(Nt5e, CD73) entdeckt, die uns die erfolgreiche Anreicherung junger Mausfotorezeptoren mit 
Hilfe von CD73-vermitteltem MACS erlaubte. Die Transplantation dieser angereicherten 
Zellpopulation in die Netzhaut von Empfängertieren resultierte in einer signifikant erhöhten 
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Integrationsrate im Vergleich zu nicht-angereicherten retinalen Zellen. Die Überprüfung der 
Nutzbarkeit weiterer identifizierter Oberflächenproteine zur Zellanreicherung bzw. die 
Übertragung der etablierten Protokolle zur Zellsortierung und Transplantation auf 
Fotorezeptoren aus ES- und iPS-Zellkulturen, sollten im Fokus nachfolgender Experimente 
stehen. 
Die Integration transplantierter Zellen in die Empfängernetzhaut ist ein komplexer Prozess und 
von unterschiedlichen Einflussfaktoren abhängig. Durch Transplantationsexperimente in 
alternden Wildtyp-Mäusen und einem Mausmodell, dessen Fotorezeptorschicht keine Stäbchen 
und stattdessen nur Zapfen und zapfenähnlichen Fotorezeptoren aufweist, konnte gezeigt 
werden, dass vor allem die Aktivierung von Müllerzellen die Integrationsrate der Fotorezeptoren 
erhöht. Neben dieser sogenannten Gliose werden weitere Faktoren, wie die reduzierte Stabilität 
der äußeren Grenzmembran, die flächenmäßig größere Verteilung der transplantierten Zellen 
im subretinalen Raum oder die reduzierte Dichte der Zellen in der äußeren Körnerschicht, als 
potentielle integrationsfördernde Komponenten in Betracht gezogen. Diese bilden interessante 
Schwerpunkte für weitere Forschungen, um eine ausreichende Zellintegration durch 
Manipulation der Empfängernetzhaut, auch in der klinischen Anwendung, zu erreichen. 
Obwohl Transplantationsexperimente zusätzlich zur Maus auch in anderen Empfängerspezies, 
wie Ratten und Schweinen, durchgeführt wurden, liegen bis jetzt keine Studien vor, die die in 
der Maus erfolgreich etablierten Protokolle der Zellanreicherung und Transplantation von 
Fotorezeptor-Suspensionen in diesen Spezies reproduzierte. Der Transfer dieser Technik und 
eine Generalisierung der Anwendbarkeit eines Fotorezeptorersatzes durch Transplantation in 
verschiedenen Säugetierarten geben jedoch wichtige Hinweise für eine mögliche Translation 
dieser Technologie für klinische Anwendungen. Deshalb haben wir unser bereits an der Maus 
getestetes Protokoll auf die Ratte übertragen und erfolgreich Fotorezeptoren der Ratte mit Hilfe 
von CD73-vermitteltem MACS angereichert. Nach deren Transplantation in die Netzhaut von 
Ratten und Mäusen zeigten die Rattenfotorezeptoren aber eine stark verminderte 
Integrationsfähigkeit und das Fehlen einer reifen Fotorezeptormorphologie. Speziell in Hinsicht 
auf eine zukünftige klinische Anwendung sind diese Ergebnisse relevant, da sie die Frage 
aufwerfen, ob die mangelnde Integration in der Ratte ein generelles Problem darstellt und daher 
auch beim Menschen zu erwarten ist, oder ob sie nur eine Ausnahme im Rattenmodell bildet. 
Aus diesem Grund bildet die weitere Erforschung der zellulären und molekularen Mechanismen 
der Integration transplantierter Fotorezeptoren eine wichtige Grundlage für die Entwicklung 
einer sicheren und effizienten Therapie mit dem Ziel, degenerative Netzhauterkrankungen zu 
heilen.  
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Reduced visual perception or total blindness cause dramatic changes in life of affected people. 
Although a variety of helping tools for diseased people is available, life quality is often drastically 
reduced. 
Worldwide, estimated 285 million people are visual impaired, including 39 million people being 
blind (Pascolini and Mariotti 2012). The leading causes for global visual impairment are 
uncorrected refractive errors (43 %) and cataracts (33 %), whereas blindness is primarily 
provoked by cataracts (51 %), followed by glaucoma (8 %) and AMD (5 %) (Pascolini and 
Mariotti 2012). 
Due to the better accessibility of cataract surgeries in western countries, global statistics do not 
entirely represent region specific numbers. In high income countries like England, Wales or 
Germany, non-curable degeneration diseases of the retina, mainly caused by AMD, head the 
list (Bunce and Wormald 2006). Further aging of western populations and the lack of a suitable 
therapy to cure retinal degenerative diseases make the development of proper treatments a 
relevant research aim. Knowledge about the eye and retinal morphology, besides investigating 
the mechanisms underlying retinal degenerative diseases, form the foundation for this research 
and are subject of the following chapters. 
 
1.1 Gross anatomy of the eye and the retina 
 
The eye is a highly specialized, multilayered organ (Figure 1, left) and allows human beings to 
detect light with wavelength between 400 and 750 nm    ll ann-Rauch 2012). The outer layer 
(tunica fibrosa bulbi) is composed of the sclera, containing collagen fibers and giving the eye its 
stability and shape, and the transparent cornea, covering the front of the eye and forming the 
first light focusing structure. The intermediate layer is called uvea (tunica vasculosa bulbi) and 
consists of the choroid, the ciliary body and the iris. The choroid is highly vascularized and 
provides nutrients and oxygen for the outer parts of the eye´s internal layer, called retina. The 
pigmented iris is a circular colored structure, visible underneath the cornea. Its center forms the 
pupil, whose size is regulated by the iris muscles and depends on the light intensities entering 
the eye. The ciliary body produces the aqueous humor for the anterior and posterior chambers 
of the eye and contains the ciliary muscle, that operates the accommodation of the lens and 
allows focusing objects at close as well as far distances via changes of its shape, directly 
affecting the lens´ light refraction    ll ann-Rauch 2012). 
 
7 
 
 
Figure 1: Anatomy of the eye and enlarged view of the retina 
This schematic drawing depicts the multilayered eye (left), containing an external layer formed by sclera, cornea and 
conjunctiva (not shown), the intermediate layer, consisting of choroid, ciliary body and iris, and the internal retina. 
After passing the cornea, aqueous humor, lens and vitreous body, light crosses the multilayered retina, is detected by 
rod and cone photoreceptors and processed by second order neurons (right). The axons of the ganglion cells form 
the optic nerve and transfer the incoming signal to the visual centers of the brain. INL: inner nuclear layer, IPL: inner 
plexiform layer, ONL: outer nuclear layer, OPL: outer plexiform layer, RGC: retinal ganglion cell layer, RPE: retinal 
pigment epithelium. Adopted from Kolb (1995a). 
 
After passing the cornea, aqueous humor, lens and vitreous body, the light is detected by the 
retina (tunica interna bulbi) (Figure 1, left and magnification right). Its composition of highly 
specialized neuronal and non-neuronal cell types allows processing of incoming light and its 
final transfer to the optical centers of the brain.  
The retina is stratified into three nuclear layers, containing the cell bodies of retinal neurons, and 
two plexiform layers, build from the cells´ synapses and axons (Kolb 1995a). The outer nuclear 
layer (ONL) contains the cell bodies of cone and rod photoreceptors, whereas the inner nuclear 
layer (INL) is composed of the cell bodies of horizontal, amacrine and bipolar cells. Ganglion 
cells and displaced amacrine cells are organized in the retinal ganglion cell layer (RGC; Figure 
1, right). In addition to neurons, also non-neuronal cells play important roles in maintaining 
retinal functionality. While the retinal pigment epithelium (RPE) cells form the outermost retinal 
layer, the nuclei of Müller glia cells are localized in the INL and microglia cells can be found in 
the plexiform layers of the retina.  
In the mammalian eye, the light has to pass all retinal layers before it is detected by cone and 
rod photoreceptors, the main light-sensing cells of the retina and the first cells in the cascade of 
visual processing (Figure 1, right). Their visual pigments detect photons and induce the 
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phototransduction cascade, initiating hyperpolarization of photoreceptors and synapse-mediated 
downstream signaling to second order neurons, located in the INL. Lateral connections between 
second order neurons already allow processing of the incoming signal, before it is transferred to 
the ganglion cells, having axons which form the optic nerve, which transfer the signal to the 
brain. In the following chapter, distinct retinal cell types and there functions will be discussed in 
more detail. 
 
1.2 Retinal cell types 
1.2.1 Photoreceptors and RPE cells 
 
The abilities to see in dim light, to discriminate colors and to have high visual acuity are feasible 
because of the diversity of photoreceptors and their visual pigments. The mammalian retina 
contains one type of rod and two to three types of cone photoreceptors. While the very light 
sensitive rods count in the human retina for 95 % of all photoreceptors (~120 million) and are 
responsible for dim light vision, cones make only 5 % (~6 million) of all photoreceptors and 
respond to bright light and mediate color and high acuity vision  Swaroo  et al          ll ann-
Rauch 2012). Although varying in size, the gross morphology of rods and cones is similar 
(Figure 2). Both photoreceptor types contain a cell body located in the ONL, inner and outer 
segments linked via the connecting cilium and oriented towards the RPE, and synaptic terminals 
located in the outer plexiform layer (OPL; Figure 1, right; Figure 2). While the cell body contains 
the nucleus, further organelles, mediating protein biosynthesis or energy production like 
ribosomes, Golgi apparatus or mitochondria, are located in the inner segment. The outer 
segment consists of stacked membrane discs that are produced at the base of the connecting 
cilium and are detached from the plasma membrane in rod photoreceptors, but remain attached 
to the membrane in cones (Steinberg et al. 1980). Within the discs of the outer segments, the 
light sensing photopigments, crucial for photoreceptor activation, are embedded. Photoreceptor 
synapses, called cone pedicles or rod spherules, contact bipolar and horizontal cells and 
change neurotransmitter release upon light-induced photoreceptor hyperpolarization (Kolb 
1995b). 
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Figure 2: Scheme of jawed vertebrate cone and rod photoreceptors 
Cone (left) and rod (right) photoreceptors consist of a cell body comprising the 
nucleus, an inner and outer segment connected via a cilium, and a synapse. 
While the cone outer segment is conical shaped, the rod outer segments are 
longer and rod-shaped. Also the synapses of cone and rod photoreceptors 
differ. While the cone pedicles are larger, conical and flat, the rod spherules are 
smaller and round. Adopted from Lamb (1995). 
 
 
 
 
 
 
In contrast to other mammals, cones of humans and primates are concentrated in a central rod-
depleted region of the retina, called fovea, operating as an area of central high acuity vision 
(Figure 3, left). Rods instead, are distributed all over the retina but the fovea, having their 
highest density in the parafoveal regions (Figure 3, right) (Curcio et al. 1990). The solely area 
containing no photoreceptors is the optic disc. It is also called blind spot and the place, where 
the axons of ganglion cells leave and blood vessels enter the retina. 
 
 
Figure 3: Topography of human cone and rod photoreceptors 
Computer generated color coded maps of the density of human cone (left) and rod (right) photoreceptors. Cones 
have their highest density in the center of the retina (white), next to the optic disc (black) and reveal decreasing 
density towards the periphery (blue). Rods (right) are distributed all over the retina, but the center of the fovea and 
the optic disc and have their highest density (red) at the parafoveal region. Adopted from Curcio et al. (1990). 
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The photopigments of rods and cones are called rhodopsin or cone opsin, respectively, and 
their differences in light sensitivity as well as wavelength selectivity defines the characteristics of 
the different photoreceptor types (Arshavsky and Burns 2012). The rod photoreceptor pigment 
rhodopsin is very light sensitive and detects wavelength of 498 nm (Bowmaker and Dartnall 
1980). In most mammals, further two types of cones have developed, expressing green light 
sensitive opsin (medium wavelength [M]-cones) and blue light sensitive opsin (short wavelength 
[S]-cones), detecting light at wavelengths of 530 nm and 420 nm, respectively (Kolb 1995b). 
Gene duplication in humans and primates additionally resulted in the development of a third, red 
light sensitive opsin (long wavelength [L]-cones), having its peak absorbance at 560 nm (Rowe 
2002). Thus, in contrast to many other mammalians missing this duplication event, humans and 
primates can use trichromatic vision. Worth noting is, that not only trichromatic, but also 
tetrachromatic vision in birds or butterflies (Wilkie et al. 1998; Koshitaka et al. 2008) or even 
pentachromatic vision in lampreys and lungfish (Collin 2009) were reported, enabled, e.g. by UV 
light sensitive cones. 
 
Retinal photopigments are part of the complex protein machinery of photoreceptors and enable 
the detection of photons and thus the induction of the phototransduction cascade, the initial 
event in the process of vision (Figure 4). In brief, this cascade utilizes a G protein signaling 
pathway that leads via the reduction of internal cyclic guanosine monophosphate (cGMP) 
concentrations to the closure of a cGMP-gated sodium channel in the membrane (Figure 4). 
The reduced sodium concentration inside the cell causes a hyperpolarization that finally lead to 
decreased glutamate release from photoreceptor synapses, inducing downstream signaling 
(Arshavsky and Burns 2012).  
The G protein in this cascade is called transducin and is activated by the photopigments, 
consisting of two covalently bound parts. The protein part is called opsin in rods or photopsin in 
cones and the attached chromophore is named retinal (Arshavsky and Burns 2012). While the 
opsins are produced in the inner segments of photoreceptors, retinal is synthesized in RPE cells 
from vitamin A and afterwards delivered to the photoreceptors (Kolb 1995b). Detection of 
photons induces the isomerization of retinal from its 11-cis-form to its all-trans-conformation, 
causing a conformational change of opsin to its active form, termed R* (Figure 4). Active R* 
catalyzes the GDP-GTP exchange at the G protein transducin, consisting of the subunits Gα 
and Gβγ  The activated α subunit Gα-GTP binds the γ subunit of a cGMP phosphodiesterase, 
activating the phosphodiesterase which hydrolyzes cGMP to GMP, resulting in reduced cGMP 
concentrations inside the cell. This closes cGMP-gated cation channels in the plasma 
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membrane, reducing cation influx into the outer segments and leading to hyperpolarization of 
the photoreceptor cell (Arshavsky and Burns 2012). To stop the photoresponse, all 
phototransduction proteins need to be deactivated by regulatory enzymes. Reactivation of 
photoreceptors is only possible after restoration of cGMP by guanylate cyclase and recycling of 
retinal (Arshavsky and Burns 2012). The lack of a re-isomerase in photoreceptors requires the 
transport of all-trans retinal to the RPE cells, its re-isomerization into 11-cis retinal and the 
return transport into the photoreceptors (Strauss 1995). 
 
 
Figure 4: Phototransduction cascade in rods 
After its light–dependent activation, rhodopsin (R*) activates the transducin subunit Gα via the catalyzation of a GDP-
GTP exchange. Activated Gα-GTP binds the  hos hodiesterase  PDE) subunit γ, leading to cGMP hydrolysis and 
reduced cGMP content in the cell. This closes the cGMP-gated cation channels, leading to reduced cation influx into 
the photoreceptor and a subsequent hyperpolarization. Adopted from http://webvision.med.utah.edu/book/part-v-
phototransduction-in-rods-and-cones/phototransduction-in-rods-and-cones/. 
 
Besides playing crucial roles for photopigment recycling, RPE cells have more assisting 
features, making them the most important supporting cells for photoreceptors. Hence, their 
degeneration inevitably leads to photoreceptor cell death. Due to photo-oxidative damage, 
photoreceptor outer segments undergo constant destruction and need to be renewed regularly. 
While the photoreceptors produce new discs at the connecting cilium, the tips of the outer 
segments are shed and constantly phagocytized by RPE cells (Strauss 1995). The complete 
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renewal of a rod outer segment takes 11 days. Due to their localization between the outer 
segments of the photoreceptors and the inner layer of the choroid, called Bruch´s membrane, 
RPE cells participate with their tight junctions in the formation of the retina-blood barrier, 
efficiently isolating the retina from systemic influences of the blood stream (Strauss 1995). This 
feature makes the eye an immune privileged organ and ensures the selective transport of 
nutrients from the blood stream to the photoreceptors as well as the elimination of water and 
metabolites from the retina. Besides that, the absorption of scattered light, helping to improve 
vision, maintenance of ion homeostasis in the subretinal space to confirm proper signal 
transduction and the secretion of factors and signaling molecules for communication with 
endothelial or immune cells from the blood side, are features making RPE cells essential for 
retinal functionality (Strauss 1995). 
 
1.2.2 Second order neurons and ganglion cells 
 
Second order neurons like bipolar, horizontal or amacrine cells contain nuclei located in the INL 
and play crucial roles in retinal signal processing. They receive input from photoreceptors, are 
interconnected and process incoming signals prior to the transfer to the brain (Figure 1, right).  
Up to now, 12 anatomical types of bipolar cells are known, one being directly connected to rods 
and 11 receiving cone input (Masland, 2012). Due to differential activation and deactivation of 
distinct bipolar subtypes, e.g. OFF-bipolar cells that hyperpolarize and ON-bipolar cells that 
depolarize upon photoreceptor signaling, they specify the signal and finally transmit it to the 
ganglion cells.  
In most mammals, two types of horizontal cells are known; type A, interconnecting cones only 
and type B, connecting cones and rods. They are known to work inhibitory on photoreceptors 
and thus, e.g. enable enhanced edge sharpness of objects. Another important function of 
horizontal cells is the light adaptation of certain retinal areas after measuring regional 
brightness  Thus, they allow the discri ination of dark objects, like  eo le’s faces, in front of 
bright objects, like windows to the outdoors, by reducing locally retinal sensitivity (Masland, 
2011).  
In contrast to horizontal cells, amacrine cells form a very diverse population, with approximately 
30 different types identified up to now. Their high dissimilarity in morphology and their lack of 
axons and clear polarity makes it challenging to unwire functions of distinct populations 
(Masland, 2012). However, it was shown that they serve as a link between the system of rod 
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signaling and the rest of the retina, release neurotransmitters like dopamine to control activities 
across the retina in light and darkness or create direction selectivity in ganglion cells (Masland, 
2011).  
Signals created by photoreceptors and processed by second order neurons are transferred via 
bipolar as well as amacrine cells to ganglion cells. Their axons form the optic nerve leaving the 
retina through the optic disc, and send the signal to the visual centers of the brain (Lamba et al., 
2008). The high diversity of ganglion cell dendritic architecture between different species and 
the difficulty to distinct them based on biochemical markers complicates the determination of 
total subtype numbers and creates varying suggestions between 12 and 20 different subtypes 
(Masland 2011). 
 
1.2.3 Non-neuronal cell types 
 
Non-neuronal cell types like Müller glia cells, microglia cells or RPE cells are not directly 
involved in the signal transduction process, but have important supportive functions. Müller glia 
cells, with their cell bodies located in the INL, play important roles in retinal stability and repair 
as well as providing homeostatic and metabolic support for all neuronal cells (Reichenbach and 
Bringmann 2013). They are also involved in recycling of neurotransmitters like glutamate, that is 
after its uptake by Müller glia cells converted into glutamine, a precursor for glutamate synthesis 
in retinal neurons (Reichenbach and Bringmann 2013). Retinal degeneration (Barber et al. 
2013; Bartsch et al. 2013), damage (Lamba et al. 2009), inflammation (Dinet et al. 2012), aging 
(Kim et al. 2004; Chen et al. 2010) or other factors can lead to activation of Müller glia cells, a 
process known as reactive gliosis. Under these circumstances, Müller glia cells respond with 
hypertrophy, the formation of scar like membranes (Lamba et al. 2009), changes in gene 
expression and the release of cytokines and growth factors, helping neurons to survive. 
Additionally, Müller glia cells show an increased expression of intermediate filaments like glial 
fibrilary acidic protein (GFAP) in their fibers, spanning the whole retina (Lamba et al. 2009). 
Although reactive Müller glia cells have neuroprotective function, upon activation they also 
reduce nutrient support for retinal neurons and thus might contribute to retinal degeneration 
processes (Reichenbach and Bringmann 2013). Together with photoreceptors, Müller glia cells 
form a barrier composed of tight junctions, called the OLM (Figure 1, right). This membrane is 
crucial for retinal stability and plays important roles in preventing proteins from diffusion (Omri et 
al. 2010).  
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Beside Müller glia cells, retinal microglia cells are residential macrophages, distributed in the 
inner plexiform layer (IPL) and OPL. Damage of the retina or RPE activates microglia cells, 
induces their migration and repair mechanisms, involving formation of a glial scar or 
phagocytosis (Karlstetter et al. 2010). Also here, extended activation can lead to chronic 
inflammation, causing retinal degeneration. 
 
1.3 Retinal degenerative diseases 
 
Inherited or acquired degenerations can affect the retina and lead to reduced vision or 
blindness. The leading cause for blindness in people older than 50 years in industrialized 
countries is AMD (http://www.nei.nih.gov/health/maculardegen/armd_facts.asp), a multifactorial 
disease with age, smoking, and genetic predisposition, identified as major risk factors. Damage 
of the macula area in the central retina leads to loss of the central visual field (Ramsden et al. 
2013). First sign of AMD is the deposition of debris, called drusen, between RPE and Bruch’s 
membrane (Jager et al. 2008). The drusen can damage the RPE and induce chronic 
inflammation, resulting in retinal atrophy and/or cytokine release. This form is called dry AMD or 
geographic atrophy. In the wet (exudative) AMD form, additionally choroidal neovascularization 
happens, followed by higher permeability and fragility of vessels and breaks in the Bruch´s 
membrane. Leaking vessels lead to subretinal hemorrhage, fluid exudation and detachment and 
degeneration of RPE (Jager et al. 2008). Subsequently, mainly cone photoreceptors in the 
central areas die, leading to color blindness, reduced visual acuity, difficulties while adaptation 
from bright to dim light and visual scotomas (Jager et al. 2008). In patients with dry AMD, the 
degeneration can progress over months to years, while in cases of wet AMD, sudden vision loss 
within days or weeks can occur (Jager et al. 2008). 
 
Another group of retinal degenerative diseases, having the loss of photoreceptors as main 
symptom, is summarized in the term RP. In contrast to AMD, RP is known to be inherited and 
with a prevalence of one affected person in 4,000 (about 1 million in total) relatively rare 
(Hartong et al. 2006). However, up to now more than 100 RP-causing mutations were identified 
and many of them were found in more than 45 photoreceptor-, as well as RPE-related genes, 
leading to photoreceptor loss or accumulation of RPE deposits (Hartong et al. 2006; Ramsden 
et al. 2013). Although displaying variable pathologies, in most cases initially rod photoreceptors 
degenerate, resulting in night-blindness and reduced peripheral vision. This is eventually 
followed by the degeneration of cones, leading to central vision loss and total blindness (Hamel 
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2006). Mutations in the rod specific rhodopsin gene account for the most common subtypes of 
RP, but also mutations in RPE-specific genes like RPE65 (Hamel et al. 1994; Morimura et al. 
1998) or MERTK (Gal et al. 2000) have been shown to induce RP. Depending on the disease-
causing mutation, RP can either provoke blindness within 20 years after diagnosis, or can also 
progress so slowly, that patients never get blind (Hamel 2006). 
 
1.4 Therapeutic approaches for retinal degenerations 
 
Although several therapeutic approaches were reported to slow down the progression of retinal 
degeneration, up to now it is impossible to cure these medical conditions.  
Amongst others, surgical interventions including removal of neovascularization (Hawkins et al. 
2004) or translocation of the macula towards a less affected region (Mruthyunjaya et al. 2004) 
were applied in patients, but did not lead to satisfying results. Controversially discussed as well 
is the supplementation of RP and AMD patients with antioxidants like vitamin A, C, E, 
carotenoids or zinc. This treatment is suggested to reduce degeneration, but is also supposed 
to imply certain risks. Beside other concerns, the toxicity of high vitamin A doses, when taken 
over extended time periods, or the varying absorption characteristics of vitamin A, dependent on 
formulation or the amount of dietary fat people intake, are major issues making this approach 
disputable (Berson et al. 1993; Fielder 1993; Age-Related Eye Disease Study Research Group 
2001; Gaynes 2003; Massof and Fishman 2010). 
More promising appears the intravitreal injection of antiangiogenic factors like ranibizumab 
(Lucentis, Genentech) or bevacizumab (Avastin, Genentech). These antibody fragments block 
vascular endothelial growth factor A (VEGF-A) and thus reduce neovascularization, resulting in 
reduced degeneration and increased visual acuity in patient studies (Rosenfeld et al. 2006; 
Spaide et al. 2006). Another interesting approach that already reached clinical studies and 
showed first promising results is the epi- or subretinal implantation of artificial devices with the 
aim to replace parts of the degenerated retina of patients. Beside others, the Argus II retinal 
prosthesis (Second Sight Medical Products Inc.) is implanted epiretinally into the patiens eye. 
This chip contains 60 electrodes that receive signals from an external camera mounted to a pair 
of glasses. The signal is transferred to the chip and sent via endogenous cells to the visual 
centers of the brain. It allows visual impaired patients to perform motion detection tasks which 
they were not able to do with their native vision (Dorn et al. 2013). Furthermore, patients having 
only light perception vision before transplantation, where able to identify letters and even words 
afterwards (da Cruz et al. 2013). Also the group of Prof. E. Zrenner (Centre for Ophthalmology, 
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University of Tübingen) uses a chip-based approach. The chip is transplanted subretinally and 
its 1500 microphotodiode-amplifier-electrode elements allow direct detection of light signals, 
avoiding need of external cameras. The group was able to show restored light perception, 
localization and also restored motion detection. Additionally, identification, localization and 
discrimination of objects improved significantly (Stingl et al. 2013). Further promising results 
were achieved while treating retinal dystrophy patients by gene therapy. Mutations in the gene 
RPE65 lead to early onset severe retinal dystrophy with poor vision at birth and loss of vision 
later on. Replacement of the defective gene via adeno-associated virus-mediated subretinal 
delivery of a vector encoding for RPE65 complementary deoxyribonucleic acid (cDNA) under 
the control of a human RPE65 promoter (Bainbridge et al. 2008) or ubiquitous actin promoter 
(Maguire et al. 2009), showed success in recent clinical trials. Patients reveal improvement in 
visual function on microperimetry and on dark-adapted perimeter (Bainbridge et al. 2008) and 
improvement in subjective and objective measurements of vision (dark adaptometry, 
pupillometry, electroretinography, nystagmus, and ambulatory behavior) (Maguire et al. 2009). 
Although patients vision improved significantly over short and long terms, their retina was not 
protected from further degeneration, indicating the need of a combinational therapy that 
improves function and additionally slows down retinal degeneration (Cideciyan et al. 2013). 
Although data from first gene therapy trials are promising, this approach is very specific for 
single, known mutations and can only be successful in early stages of the disease, when most 
photoreceptors are still present. In diseases like RP, which are often caused by mutations of 
unidentified genes, a rather general approach, like the replacement of degenerated 
photoreceptors, might be more suitable. 
 
1.5 Photoreceptor replacement – state of the art 
 
After degeneration of RPE and photoreceptors in AMD or RP, second order neurons or ganglion 
cells often survive many more years (Lamba et al. 2009). Thus, the direct replacement of 
degenerated photoreceptors by transplantation of stem cell-derived cell populations might be 
one usable general approach. First successful attempts to apply the idea of cell replacement to 
mice were shown by the labs of Robin Ali (UCL, London, England) and Marius Ader (CRTD, 
Dresden, Germany) (MacLaren et al. 2006; Bartsch et al. 2008). They isolated primary retinal 
cells from fluorochrome (enhanced green fluorescent protein [EGFP]) expressing donor animals 
with different ages (embryonic day [E] 11.5 up to adulthood) and transplanted them into the 
subretinal space between the RPE and the photoreceptors of wild-type mice (C57BL/6J). The 
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transplanted cells were able to integrate into the host retina and developed into cells displaying 
photoreceptor morphology, including round shaped cell bodies, synapses, inner and outer 
segments (Figure 5A). 
 
 
Figure 5: Integration of fluorochrome expressing photoreceptors into the retina of wild-type hosts after 
subretinal transplantation 
Primary retinal cells, derived from four-day-old EGFP expressing transgenic mice, integrated after their 
transplantation into the retina of wild-type mice and displayed photoreceptor characteristics, like synaptic termini 
(arrow head) in the OPL, round-shaped cell bodies (arrows) in the ONL and inner/outer segments (A, modified from 
Bartsch et al. [2008]). Retinal cells, derived from three to five-day-old mice, showed the best ability to integrate into 
the wild-type retina after transplantation (B, modified from MacLaren et al. [2006]). E: embryonic day, EGFP: 
enhanced green fluorescent protein, IS: inner segment, N: number of eyes, ONL: outer nuclear layer, OPL: outer 
plexiform layer, OS: outer segment, P: postnatal day. 
 
During these experiments it turned out, that the age of donor mice plays a crucial role for 
successful integration of transplanted cells. Young photoreceptors, postmitotic but not fully 
differentiated occurring in postnatal day (PN) 3-5 retinae, showed the highest integration rate 
after their transplantation (Figure 5) (MacLaren et al. 2006; Bartsch et al. 2008; Lakowski et al. 
2010). Nevertheless, only up to 2,500 cells, representing 0.6% of transplanted cells, fully 
integrated into the retina (Bartsch et al. 2008). To increase the integration rate of transplanted 
cells, further enrichment of photoreceptors was performed using fluorescence-activated cell 
sorting (FACS) (Lakowski et al. 2010). Mice expressing GFP under the control of regulatory 
sequences of the photoreceptor specific gene cone-rod homeobox (Crx, called CrxGFP mice), 
express GFP in post-mitotic developing and mature cone and rod photoreceptors (Samson et al. 
2009). Based on their GFP expression, photoreceptors were enriched with high purity and 
showed with a maximum of 15,000 cells ten-fold higher integration rates than unsorted fractions 
(MacLaren et al. 2006; Lakowski et al. 2010). 
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To further demonstrate the applicability of the approach for diseased patients, transplantation 
experiments into murine retinal degeneration models mimicking human retinal diseases were 
carried out, demonstrating the ability of transplanted cells to recover visual function (MacLaren 
et al. 2006; Pearson et al. 2012; Barber et al. 2013; Singh et al. 2013). Pearson et al. (2012) 
used a mouse model carrying a knockout of guanine nucleotide binding protein, alpha 
transducing 1 (Gnat1-/-), as recipient for transplantations. This model suffers from congenital 
stationary night blindness and lacks rod function. Flow-cytometric enriched EGFP-expressing 
rod photoreceptors were transplanted and integrated in high numbers (16,759 ± 1,705 cells per 
retina) into the retina of Gnat1-/- mice and exhibited photoreceptor morphology. Functionality 
and connectivity of integrated cells to the visual cortex was confirmed by optical intrinsic 
imaging (Grinvald et al. 1986) and behavioral experiments (optomotor head-tracking, water-
maze experiments) under scotopic conditions (Pearson et al. 2012). 
Although these functional data are a big step towards clinical application, suitable donor cell 
sources still need to be further developed. Primary retinal cells with the ability to integrate need 
to be isolated from four-day-old mice, corresponding to developmental stage of human fetal 
retinal cells in the second trimester of pregnancy. These human cells cannot be used as 
sources for cell replacement and therefore, human and murine ES cells (Eiraku and Sasai 2012; 
Nakano et al. 2012) as well as iPS cells (Meyer et al. 2009; Lamba et al. 2010) were 
differentiated in vitro into photoreceptor containing cell populations. Especially recent 
publications are impressive, demonstrating the in vitro generation of optic-cup like structures out 
of human ES cells, resembling retinal stratification (Nakano et al. 2012). The formation of 
ganglion cells expressing the specific marker brain-specific homeobox/POU domain protein 3 
(Brn3), calretinin-positive amacrine cells and also photoreceptor marker (neural retina leucine 
zipper [Nrl], recoverin and rhodopsin) expressing cells was observed (Nakano et al. 2012). 
Recently, the group of Robin Ali (UCL, London, England) used a modification of the original 
protocol, established by Mototsugu Eiraku and Yoshiki Sasai (Eiraku et al. 2011), to generate 
murine ES cell-derived photoreceptors. These cells were transplanted into the retina of wild-type 
and diseased animals (Gonzalez-Cordero et al. 2013). The generated photoreceptors were 
enriched via FACS, mediated by viral infection with a construct containing rhodopsin promoter 
driven GFP expression. The cells were transplanted into the subretinal space of different 
degeneration models and achieved best morphology in Gnat1−/− mice with 420 ± 98 integrated 
cells per retina (Figure 6).  
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Figure 6: Transplanted ES cell-derived photoreceptors integrate into the Gnat1
-/-
 
retina 
Upon their transplantation, ES cell-derived and flow cytometry-enriched photoreceptors 
integrated into the retina of Gnat1
-/-
 mice and developed into morphological mature 
photoreceptors, expressing the rod marker transducin. ONL: outer nuclear layer. Adopted 
from Gonzalez-Cordero et al. (2013). 
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1.6 Aim of the study 
 
In the past years, the treatment approach of retinal cell replacement evolved from initial 
transplantations of primary retinal cells, the specific enrichment of rod photoreceptors and the 
transplantation into mouse models mimicking human retinal degenerations, until the successful 
differentiation of ES cells into photoreceptors, followed by retinal integration after 
transplantation. Although these observations are encouraging, prior to a save implementation of 
this strategy into a clinical routine, several further hurdles need to be challenged. 
 
In my PhD thesis, divided into three parts, I focused on some of these issues.  
 
1. The recently reported enrichment of photoreceptors was achieved by FACS, facilitating 
genetically modified cells expressing fluorochromes. For the implementation of this 
approach into a clinical routine, the utilization of genetically engineered cells should be 
avoided. Therefore, we screened the transcriptome of young rod photoreceptors to identify 
specific cell surface markers and utilized them to establish a sorting method for 
photoreceptors, eliminating the need of genetic modification. 
 
2. First studies suggested that components of the host environment have significant influence 
on donor photoreceptor migration within the host tissue. By transplantation experiments into 
aging mice as well as a rod-depleted mouse model, containing a retina composed of cone 
and cone-like photoreceptors, we identified, amongst others, the activation of Müller glia 
cells as important enhancer for retinal cell integration. 
 
3. Most transplantation studies, aiming for the replacement of degenerated photoreceptors, 
were executed in mice, leaving other species not well understood. However, prior to 
translation of this approach to human patients, further understanding and experience in 
different organisms is required. Here, the enrichment of photoreceptors derived from rats by 
cell surface marker dependent sorting was established. The subsequent transplantation of 
these enriched cells into the retinae of mice or rats revealed a reduced integration capacity 
and the lack of photoreceptor characteristics.   
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2 Identification of rod specific surface proteins 
and CD73-mediated photoreceptor enrichment 
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2.1 Introduction 
 
Enrichment of primary photoreceptors (Lakowski et al. 2010; Eberle et al. 2011; Lakowski et al. 
2011; Eberle et al. 2012; Pearson et al. 2012; Barber et al. 2013) or photoreceptors derived 
from ES cells (Gonzalez-Cordero et al. 2013) was shown to be a necessary step to receive 
increased integration rates and to reduce the risk of tumor formation after transplantation. In 
recent studies (Lakowski et al. 2010; Pearson et al. 2012; Barber et al. 2013; Gonzalez-Cordero 
et al. 2013), enrichment of cells was achieved via FACS, using genetically modified target cells 
expressing fluorochromes. Using transgenic mice or introducing fluorochrome encoding vectors 
into target cells represents a useful approach in research, but is challenging to utilize in a 
clinical setting. An alternative might be a method taking advantage of cell surface molecules of 
target cells for enrichment, like MACS (Miltenyi Biotec, Bergisch Gladbach, Germany). In this 
approach, a cell-specific surface molecule is bound by an antibody, coupled to a magnetic bead. 
The cell solution is applied to a column attached to a magnet, retaining magnetically labeled 
cells and letting flow through unlabeled cells. After removing the column from the magnet, 
labeled cells can be collected. Despite being a fast and mild procedure (Eberle et al. 2011), this 
technique is also easier to introduce into a good manufacturing practice routine, because most 
used parts can be sterilized or are disposable. However, using this approach requires the 
identification of cell surface molecules being specific for transplantable photoreceptors.  
In this part of my thesis, I describe the identification of cell surface proteins that are specific for 
young photoreceptors and prove the feasibility of MACS procedure to enrich donor cells, leading 
to increased integration rates after subretinal transplantation. The data presented here were 
published recently in Eberle et al. (2011) and Postel et al. (2013). 
 
2.2 Results 
2.2.1 Cell sorting and microarray 
 
Recent studies demonstrated that cell suspensions isolated from the mouse retina at PN3 to 
PN5 have the highest integration rate after transplantation into the adult mouse retina 
(MacLaren et al. 2006; Bartsch et al. 2008; Lakowski et al. 2010). Therefore, murine retinae 
used in the present study for isolation of photoreceptors were dissected at PN4. To identify 
genes that are specifically expressed in young rod photoreceptors, we used mice, carrying a 
human rhodopsin gene fused to EGFP (rhoEGFP mice, Figure 7A), and performed microarray 
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analysis to compare gene expression of FAC-sorted rhoEGFP-positive and -negative cells 
isolated from PN4 mice. To further specify the profile of rhoEGFP-positive photoreceptors, their 
gene expression was additionally compared to nestin-EGFP-positive cells, isolated at PN0 from 
the nestin-EGFP mouse (Figure 7B). The intermediate filament protein nestin is highly 
expressed during retinal development and thus labels retinal progenitor cells. 
 
 
Figure 7: Retinal section of PN4 rhoEGFP and PN0 nestin-EGFP mice 
In PN4 rhoEGFP mice, human rhodopsin gene is fused to EGFP, thus labeling rod photoreceptors (A). Retinal 
progenitors in PN0 mice are characterized by the expression of nestin, allowing their labeling by a nestin-EGFP 
construct in transgenic nestin-EGFP mice and their FACS-mediated enrichment (B). DAPI: 4', 6-diamidino-2-
phenylindole, INL: inner nuclear layer, NBL: neuroblast layer, ONL: outer nuclear layer, RGC: retinal ganglion cell 
layer. Scale bar: 50 µm. 
 
FACS was established for PN4 rhoEGFP (histograms and statistic shown in Figure 8) and PN0 
nestin-EGFP (statistic shown in Figure 8B) retinal cells. In the unsorted retinae of PN4 rhoEGFP 
mice, 23.8 % ± 2.9 % of cells expressed EGFP and therefore represented rod photoreceptors 
(Figure 8A, B). Enriched populations showed high purity of 89.6 % ± 2.7 % in rhoEGFP-positive 
and 99.8 % ± 0.1 % in rhoEGFP-negative fractions (Figure 8A, B, GFP+ sorted, GFP- sorted, 
respectively). The vitality of FAC-sorted cells was evaluated with propidium iodate staining and 
revealed survival rates of 78 % ± 5.4 % in the GFP-positive and 77.5 % ± 5.6 % in the GFP-
negative fraction (not shown). Enrichment of PN0 nestin-EGFP cells further resulted in a 
population containing 92.9 % ± 1.5 % EGFP-expressing cells (Figure 8B, GFP+ sorted). 
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Figure 8: Flow cytometry of PN4 rhoEGFP and PN0 nestin-EGFP retinal cells 
While unsorted retinae of PN4 rhoEGFP mice contained 23.8 % ± 2.9 % EGFP-positive rod photoreceptors (A, B; 
unsorted), the FACS enriched rhoEGFP-positive fraction contained 89.6 % ± 2.7 % rod photoreceptors (A, B; GFP+ 
sorted). The rhoEGFP-negative fraction was depleted of GFP-expressing photoreceptors and had a purity of 99.8 % 
± 0.1 % (A, B; GFP- sorted). Similar results were obtained for the PN0 nestin-EGFP mice. While in average 49.9 % ± 
2.4 % (B; unsorted) of the primary unsorted cells were GFP-positive, the GFP-positive fraction had a purity of 92.9 % 
± 1.5 % (B; GFP+ sorted) and the GFP-negative sorted fraction contained almost no GFP-positive cells (0.1 % ± 0.1 
%; B; GFP- sorted). GFP: green fluorescent protein. ANOVA: **p < 0.01. 
 
By mircoarray analysis of sorted fractions, we identified 8354 significantly changed entities 
(analysis of variance [ANOVA]: p < 0.05), containing 1125 entities being two-fold higher 
expressed in PN4 rhoEGFP-positive cells in comparison to PN0 nestin-EGFP-positive sorted 
cells (Figure 9A) and PN4 rhoEGFP-negative sorted cells (Figure 9B). These 1125 entities 
represent 744 genes. The resulting data were deposited on the National Center for 
Biotechnology Infor ation’s  NCBI, Bethesda, USA) Gene Expression Omnibus (GEO) (Edgar 
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et al. 2002) with the GEO Series accession number GSE29318 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE29318) and published in Eberle et al. (2011). 
 
  
Figure 9: Differentially expressed genes between PN4 rhoEGFP-positive sorted cells vs. control populations 
PN0 nestin-EGFP-positive and PN4 rhoEGFP-negative 
Scatterplots show 1125 more than two-fold (green lines) higher and 1948 more than two-fold lower expressed entities 
in PN4 rhoEGFP-positive cells versus PN0 nestin-EGFP-positive cells (A) and PN4 rhoEGFP-positive versus PN4 
rhoEGFP-negative cells (B). The photoreceptor specific cell surface molecule CD73 is indicated by a pointer and a 
green symbol (A, B). Modified from Eberle et al. (2011). 
 
2.2.2 Microarray data analysis 
 
We identified in the PN4 rhoEGFP-positive cell population photoreceptor specific genes like 
rhodopsin, the gamma subunit of the guanine nucleotide binding protein (Gngt1), recoverin and 
others more than two-fold higher expressed than in the control fractions, confirming the 
specificity of cell enrichment with FACS (Table 1). GeneSpring GX 11.0.1 software (Agilent 
Technologies, Santa Clara, CA) allowed initial enrichment of entities using cell membrane-
specific gene ontology terms. We identified 120 entities, representing 79 different transcriptional 
units, containing e.g. the alpha subunit of the cyclic nucleotide gated channel alpha 1 (Cnga1), 
CD73 (highlighted in Figure 9), protocadherin 15 and gap junction protein epsilon 3 (Gje1) as 
potentially photoreceptor specific (Table 1). 
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Table 1: Photoreceptor and cell surface marker that are more than two-fold higher expressed, identified in 
PN4 rho-EGFP-positive sorted fractions. Adopted from Eberle et al. (2011). 
 
 
Initial analysis of microarray data via Gene Spring was complemented using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) (Huang et al. 2009). DAVID allows 
the specific enrichment of entities using gene ontology ter  “to ological do ain: extracellular” 
to receive potential extracellular targets. Additionally, cadherin 13 (Cdh13) and the potassium 
voltage-gated channel subfamily V member 2 (Kcnv2) were added to the candidate list as they 
showed more than 2.5-fold higher expression and are known to contain extracellular domains 
(Wu et al. 2006; Philippova et al. 2009), but did not show up during DAVID analysis. A 
subsequent literature search was performed with all entities using publicly available platforms, 
including pubmed (http://www.ncbi.nlm.nih.gov/pubmed), eurexpress (http://www.eurexpress.
org/ee/), uniprot, (http://www.uniprot.org/), biogps (http://biogps.org/#goto=welcome) and others, 
to identify genes that are known (1) to be not ubiquitously expressed, or (2) to be expressed in 
the photoreceptor layer only, or (3) to have unknown expression patterns, for identification of 
new potential photoreceptor specific genes. This analysis revealed 15 genes that were chosen 
for further investigation.  
To check, whether these candidates are specific for retina only or are also expressed in other 
tissues, reverse transcriptase polymerase chain reaction (RT-PCR) analysis for different organs 
in PN4 mice was performed (Figure 10). Cnga1 and the voltage-dependent calcium channel 
subunit alpha 2/delta 4 (Cacna2d4) were expressed in the retina only and thus might be retina 
specific, whereas protocadherin 21 (Pcdh21), cell adhesion molecule 2 (Cadm2), and ATPase 
class I type 8A member 2 (Atp8a2) revealed additional expression in the brain. Kcnv2 showed a 
supplemental band in the kidney (Figure 10A). Although the primers were selected for high 
specificity, a second band showed up in the RT–PCR for Cadm2 that might represent the 
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shorter transcriptional isoform two of the gene. All candidates depicted in Figure 10A were 
selected for further investigation via in situ hybridization (ISH) or immunohistochemistry. 
3632451O06Rik (uncharacterized protein C14orf37 homolog), Furthermore, 6330442E10Rik 
(transmembrane protein 229b [Tmem229b]), adenylate cyclase 6 (Adcy6), ATPase class VI type 
11A (Atp11a), betacellulin (Btc), Cdh13, DnaJ homolog subfamily C member 16 (Dnajc16), 
integrin alpha-3 (Itga3), low-density lipoprotein receptor-related protein 4 (Lrp4) and sushi 
domain-containing protein 2 (Susd2) were also identified from the microarray data sets as 
higher expressed in young photoreceptors than in the other evaluated retinal cell populations 
and might thus be specific for photoreceptors in the retina. RT–PCR for different tissues in the 
four-day-old mice confirmed the high expression of these genes within the retina, but also 
revealed a wide distribution within the murine body (Figure 10B). Thus, they were excluded from 
further investigation. 
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Figure 10: Analysis of gene expression from candidates identified by microarray and enriched with DAVID in 
different tissues of PN4 mice 
The expression of genes selected from microarray data sets and enriched with DAVID was analyzed in different 
tissues of four-day-old mice. RT-PCR reveals that Atp8a2, Cacna2d4, Cadm2, Cnga1, Kcnv2 and Pcdh21 were 
expressed prominently in the retina and only a few additional tissues (A), whereas 3632451O06Rik (uncharacterized 
protein C14orf37 homolog), 6330442E10Rik (Tmem229b), Adcy6, Atp11a, Btc, Cdh13, Dnajc16, Itga3, Lrp4 and 
Susd2 were ubiquitously expressed (B). SDHA was used as a housekeeping gene. Adopted from Postel et al. (2013). 
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ISH was performed with selected genes, which turned out to be highly expressed in the four-
day-old murine retinae and only a few additional organs (Atp8a2, Cacna2d4, Cadm2, Kcnv2; 
Figure 10A). Atp8a2 (Figure 11A) and Cadm2 (Figure 11E) were expressed in the developing 
INL, ONL, and the RGC in the retinae of four-day-old mice. In adult mice, Atp8a2 (Figure 11B) 
and Cadm2 (Figure 11F) were expressed in the mature INL, ONL, and RGC, although Atp8a2 
expression in the INL was weaker than in the ONL. Cacna2d4 (Figure 11C) and Kcvn2 (Figure 
11G) revealed restriction to the developing photoreceptor layer in the retinae of four-day-old 
mice. In adult mice, Kcnv2 expression was restricted to the ONL (Figure 11H), while Cacna2d4 
expression was also observed in the INL (Figure 11D). 
 
Figure 11: ISH of selected candidates 
The expression patterns of selected 
candidates in four-day-old and adult mice 
were analyzed with ISH. Cacna2d4 and 
Kcnv2 were expressed in the developing 
photoreceptor layer in four-day-old retinae 
and in the ONL of adult retinae (C, D, and 
G, H). Cacna2d4 showed additional 
expression in the mature INL (D). Atp8a2 
and Cadm2 were expressed in four-day-
old ONL, INL and RGC (A, E). Expression 
throughout the retina was observed in 
adult animals (B, F). Attached smaller 
images represent the corresponding sense 
controls for each staining. AS: anti sense, 
INL: inner nuclear layer, NBL: neuroblast 
layer, ONL: outer nuclear layer, RGC: 
retinal ganglion cell layer, S: sense. Scale 
bar: 50 µm. Adopted from Postel et al. 
(2013). 
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Pcdh21 showed more than 3.5-fold higher expression in the microarray data sets of PN4 rho-
EGFP mice and RT–PCR analysis suggested high specificity for the retina in four-day-old mice. 
Due to the availability of an extracellular binding antibody which could potentially also be used 
for MACS mediated enrichment, Pcdh21 localization in mouse retinae was directly tested by 
immunohistochemistry (Figure 12). Nrl-EGFP mice, showing EGFP signals in developing 
(Figure 12B) and mature (Figure 12F) rod photoreceptors, were used to visualize the 
photoreceptor layer. In the retinae of the four-day-old mice, Pcdh21 staining was restricted to 
the tips of developing photoreceptors (Figure 12A–D). A punctuated staining was observed at 
the connecting cilium region between the outer and inner segments of the photoreceptors in the 
retinae of adult mice (Figure 12E–H). Although we were able to localize Pcdh21 expression at 
the tips of the developing photoreceptors in PN4 mice, enrichment via MACS did not allow the 
generation of pure photoreceptor fractions (data not shown). 
 
Figure 12: Staining for Pcdh21 in the four-day-old and 
adult Nrl-EGFP retina 
Pcdh21 staining occurred in photoreceptors in the retina of 
PN4 and adult Nrl-EGFP mice. EGFP was expressed in 
developing (B) and mature (F) rod photoreceptors. Pcdh21 
was localized at the tip of the developing inner segment in 
the retina of four-day-old mice (A, C, D). In the adult 
retina, Pcdh21 staining was observed at the connecting 
cilium between the inner and outer segments (E, G, H). D 
and H show magnifications of C and G, respectively. 
DAPI: 4', 6-diamidino-2-phenylindole, INL: inner nuclear 
layer, IS: inner segments, NBL: neuroblast layer, Nrl: 
neural retina leucine zipper, ONL: outer nuclear layer, OS: 
outer segments, Pcdh21: protocadherin 21, RGC: retinal 
ganglion cell layer. Scale bar in C representative for A and 
B and scale bar in G representative for E and F: 50 μ   
Scale bars in D and H:    μ   Adopted from Postel et al. 
(2013). 
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2.2.3 CD73-mediated photoreceptor enrichment and transplantation 
 
The glycosylphosphatidylinositol-anchored cell surface molecule CD73 was identified being 
more than three-fold higher expressed in young rod photoreceptors (highlighted in Figure 9, 
Table 1) and was, due to the availability of a commercial antibody, directly tested for MACS on 
PN4 photoreceptors and subsequent transplantation by my colleagues Sandra Grahl and 
Dominic Eberle (Eberle et al. 2011). 
For evaluation of CD73-binding and MACS, PN4 Nrl-EGFP mice and rhoEGFP mice were used 
and results were confirmed by flow cytometry. Cells were dissociated and labeled with anti-
CD73 antibody and binding was evaluated with allophycocyanin (APC)-conjugated antibody. 
Flow cytometry quantification showed, that unsorted retinal cell mixtures contained 53 % ± 5.25 
% Nrl-EGFP expressing (Figure 13Ai, B) and 41 % ± 3.35 % rhoEGFP expressing (Figure 13Ci, 
D) rod photoreceptors. After enrichment of these populations via CD73-mediated MACS, the 
CD73-positive cell fractions (CD73+) showed a significantly increased number of Nrl-EGFP-
positive (87 % ± 6.33 %; Figure 13Aiii, B) and rhoEGFP-positive (74 % ± 9.95 %; Figure 13Ciii, 
D) cells. Furthermore, in the MACS-flowthrough (CD73-) the amount of Nrl-EGFP and rhoEGFP 
expressing cells was significantly reduced (25.0 % ± 2.96 %; Figure 13Aii, B; 6.0 % ± 2.3 %; 
Figure 13Cii, D, respectively). 
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Figure 13: Analysis of unsorted and MAC-sorted CD73-negative and CD73-positive retinal cells, isolated from 
PN4 retinae of Nrl-EGFP and rhoEGFP mice 
Quantification of dissociated retinal tissue from Nrl-EGFP mice by flow cytometry, immediately following CD73-based 
MACS, revealed a significant increase in GFP-positive cells in CD73-positive fractions (Aiii, B, CD73+) in comparison 
to unsorted cell fractions (Ai, B), whereas the number of GFP-positive cells significantly decreased in CD73-negative 
fractions (Aii, B, CD73-). Similar results were obtained after quantification of cells isolated from rhoEGFP transgenic 
retinae (C, D). Note the higher number of GFP-negative cells in CD73-positive fractions sorted from rhoEGFP (Ciii) in 
comparison to Nrl-EGFP (Aiii) retinae. n: number of experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Modified from 
Eberle et al. (2011). 
 
For transplantation of unsorted, CD73-positive sorted and CD73-negative sorted cells into the 
subretinal space of wild-type animals, PN4 rhoEGFP/DsRed mice were used as donors. In 
these mice, EGFP is fused to the human rhodopsin protein (Chan et al. 2004) and thus 
transported into the outer segments of mature photoreceptors, allowing their visualization. 
Additionally, these animals ubiquitously express the actin-DsRed transgene, labeling the cell 
body and allowing the quantification of integrated cells (Figure 14). Transplanted cells integrated 
into the retina of host mice and formed morphological mature photoreceptors, containing 
DsRed-positive cell bodies (Figure 14D, CB), inner segments (Figure 14D, IS) and EGFP-
positive outer segments (Figure 14D, OS). The transplantation of unsorted or CD73-negative 
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cells resulted in integration of 680 ± 410 cells/retina or 144 ± 102 cells/retina, respectively, while 
in the CD73-positive sorted fraction 2199 ± 1006 cells/retina integrated, representing a three-
fold increase (Figure 14E). 
 
  
Figure 14: Integration of MACS-isolated donor cells into adult retinae 
Unsorted, CD73-negative and CD73-positive retinal cells isolated from rhoEGFP/DsRed mice at PN4 were 
transplanted into the subretinal space of adult wild-type mice. DsRed expressing donor cells integrated into the ONL 
of hosts and developed the morphology of mature photoreceptors, including a round cell body (D, CB) located in the 
ONL, an axonal terminal (D, AT) in the OPL, and an inner segment (D, IS) above the ONL. In addition, most donor 
cells generated an outer segment identified by the distinct expression of EGFP at the tip of the donor photoreceptors 
(A–C; a magnification of a donor photoreceptor is shown in D). Whereas the integration rate of CD73-negative cells 
was low (144 ± 102 cells/retina; B, E), many cells from unsorted fractions were found in the ONL (680 ± 410 
cells/retina; A, E). Transplantation of CD73-positive cell fractions significantly increased the number of integrated 
donor photoreceptors (2199 ±1006 cells/retina; C, E). AT: axonal terminal, CB: cell body, DAPI: 4', 6-diamidino-2-
phenylindole, INL: inner nuclear layer: IS: inner segment, OPL: outer plexiform layer, ONL: outer nuclear layer, OS: 
outer segment. Scale bar: A–C: 50 µm, in D: 10 µm. ANOVA: *p < 0.05, **p < 0.01. Modified from Eberle et al. 
(2011). 
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This transplantation data demonstrated that MACS based on CD73 antibodies is a reliable 
method for the enrichment of transplantable photoreceptors, resulting in an increased number of 
donor photoreceptors that successfully integrate into the adult mouse retina. 
 
2.3 Discussion 
 
We analyzed 744 genes identified with microarray experiments and did subsequent enrichment 
with DAVID, to specify the genes expressed in young, transplantable photoreceptors and 
encode for proteins localized at the cell surface. We excluded several entities by literature 
search, because they were ubiquitously expressed and are therefore not specific for young 
photoreceptors. Atp8a2, Cacna2d4, Cadm2, Cnga1, Kcnv2, and Pcdh21 were identified with 
RT–PCR as expressed in the retina and only a few additional tissues. ISH and 
immunohistochemistry showed high specificity of Cacna2d4, Kcnv2 and Pcdh21 for 
photoreceptors in the retinae of four-day-old mice. CD73 was due to the availability of a 
commercial antibody tested for MACS and transplantations and turned out to be a useful 
candidate for photoreceptor enrichment.  
The cell surface molecule CD73 was identified being higher expressed in young photoreceptors 
of four-day-old mice by with microarray analysis, confirming data reporting its expression on rod 
photoreceptors (Koso et al. 2009). CD73 catalyzes the extracellular conversion of 5´-adenosine 
monophosphate to adenosine (Zimmermann 1992). Using anti-CD73 antibody, we established 
enrichment of rod photoreceptors with MACS and reached a purity of approximately 87% (i.e., 
Nrl-EGFP-positive cells). Notably, transplantation of CD73-enriched cell fractions into adult 
mouse retinae showed a significantly increased integration potential in comparison to unsorted 
cells. This important finding demonstrates that purification of the proper cell type before 
transplantation is highly important for increasing integration rates and that young photoreceptors 
rather than retinal progenitors, which are mainly contained in the CD73-negative fractions, have 
the potential to integrate into the ONL. Although CD73 is specific for young photoreceptors in 
the retina of young mice, its expression was also reported from other tissues, including renal 
progenitor cells (Bussolati et al. 2013) or natural killer cells (Wu et al. 2012). Recently, also the 
expression in mouse ES cells and neuronal progenitors was demonstrated (Gonzalez-Cordero 
et al. 2013). This might lead to problems while enriching photoreceptors derived from ES or iPS 
cell cultures, because CD73 might also bind unwanted cells resulting in contaminated 
photoreceptor populations. For this reason, more specific candidates like Cacna2d4, Kcnv2, 
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Pcdh21 and Cnga1 should be considered as suitable cell surface targets for MACS-mediated 
enrichment of transplantable donor cells.  
Cacna2d4 is the subunit of a voltage-dependent calcium channel that regulates its activation 
and inactivation and the calcium current density (Wycisk et al. 2006). Mutations in Cacna2d4 
cause cone-rod dysfunction, and the corresponding mouse model showed a decrease in rod 
photoreceptors. However, the number of cone cells was not affected until 6 weeks of age. 
Additionally, substantial loss in the activity of retinal second order neurons was observed 
(Wycisk et al. 2006), corresponding to the observation of our ISH analysis that showed 
expression of Cacna2d4 in the ONL and INL of adult mice. Although Cacna2d4 is expressed in 
the INL in adulthood, it represents a promising candidate for MACS-mediated photoreceptor 
enrichment due to its high specificity to photoreceptors in the four-day-old murine retina and the 
large extracellular N-terminus, suitable for generating extracellular binding antibodies.  
Kcnv2 is a subunit of a voltage-gated potassium-channel and forms heteromultimers with other 
subunits. In response to depolarization, the channel selectively transfers potassium ions through 
the plasma membrane. RT–PCR from adult mice showed high expression in the heart and eye 
and lower expression in the lung, cerebellum, and cerebrum. ISH showed expression in the 
ONL of the adult mouse and in the eye of perinatal rats (Czirják et al. 2007). Kcnv2 was 
identified during a screening as the disease-causing gene for the retinal condition cone 
dystrophy with supernormal rod electroretinogram, and ISH was performed on human retinal 
tissue showing high levels of Kcnv2 expression in the photoreceptor layer (Wu et al. 2006). 
Patients with cone dystrophy with supernormal rod electroretinogram showed reduced and 
delayed electroretinograms but an exaggerated rod response due to higher light intensities (Wu 
et al. 2006). The alterations in cone signaling indicate that Kcnv2 is also expressed in cone 
photoreceptors. We also showed the restriction of Kcnv2 expression to the retina, brain, and 
kidney of four-day-old mice and the high specificity of Kcnv2 to the developing photoreceptor 
layer of the four-day-old retina. Although generating an extracellular binding antibody against 
Kcnv2 might be challenging because of its four short extracellular domains (Wu et al. 2006), it 
seems to be an interesting target for photoreceptor enrichment via MACS technology.  
Pcdh21 was shown to be expressed in photoreceptors and localized at the base of the outer 
segments of cones and rods and at the edges of evaginating discs (Rattner et al. 2001). It is 
supposed to play a role in protein trafficking between the inner and outer segments (Rattner et 
al. 2001). Using RT-PCR, we demonstrated that Pcdh21 is expressed in the retinae and brains 
of four-day-old mice and verified its localization to the apical tip of the developing segment in the 
four-day-old retina. In addition, MACS was tested with Pcdh21 antibody but unfortunately did 
36 
 
not lead to successful enrichment of young photoreceptors (data not shown). One reason for 
this finding might be the restricted localization of Pcdh21 to the tip of young photoreceptors and 
indicates that for successful MACS the target antigen needs to cover a bigger area of the cell 
surface.  
In our RT–PCR analysis, Cnga1 expression was detected in the retinae of four-day-old mice. 
Three units of Cnga1 and one unit of Cngb1 form together a cyclic guanosine monophosphate–
gated cation channel in the plasma membrane of rod photoreceptors. This channel allows the 
hyperpolarization of the cells as the final step in the phototransduction cascade (Weitz et al. 
2002). Cnga1 consists of cytoplasmic N- and C-termini, six membrane-spanning subunits, and a 
pore-forming loop. Due to its high specificity to rod photoreceptors, Cnga1 might be a good 
target for MACS-mediated enrichment of young photoreceptors. 
Unfortunately, up to date no suitable antibodies binding target proteins Cacna2d4, Kcnv2 or 
Cnga1 at their extracellular domains and thus allowing MACS-mediated enrichment, are 
commercial available. For this reason, next steps should now involve designing and producing 
highly specific antibodies for these targets, enabling enrichment and purification of 
photoreceptors. These antibodies should first be tested with primary retinal cells from transgenic 
mice, containing rod photoreceptors expressing fluorescent reporter molecules, to verify 
successful enrichment. Then, this approach should be translated to photoreceptors generated 
from in vitro expandable stem cell sources. Differentiation of ES or iPS cells into retinal cell 
types has been established by several groups (Meyer et al. 2009; Lamba et al. 2010; Eiraku and 
Sasai 2012; Nakano et al. 2012), including the generation of transplantable rod photoreceptors 
that showed the potential to integrate into murine hosts (Gonzalez-Cordero et al. 2013). In the 
last mentioned study, the generated photoreceptors were enriched via FACS, mediated by viral 
infection with a construct, containing rhodopsin promoter driving GFP expression (Gonzalez-
Cordero et al. 2013). Using a sorting approach independent from genetically encoded 
fluorochromes with Cacna2d4 or Cnga1, for example, to enrich in vitro generated 
photoreceptors, would avoid the need for viral infection and genetic manipulation of donor cells, 
and lead to easier clinical application. Given the improved protocols for generating purely neural 
lineages from pluripotent stem cells, including retinal tissue and photoreceptors (Meyer et al. 
2009; Lamba et al. 2010; Eiraku et al. 2011; Nakano et al. 2012; Gonzalez-Cordero et al. 2013), 
antibodies against cell surface markers that are expressed in photoreceptors and additionally in 
several other tissues but not the brain (e.g., 6330442E10Rik, Btc, Lrp4), might also represent 
promising candidates for rod photoreceptor enrichment. Furthermore, a method for increasing 
the purity of enriched photoreceptor precursors and avoiding contamination by unwanted cell 
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types might be a pull-down approach, using two antibodies for sorting. Protocols have been 
established showing the feasibility of subsequent positive selections by MACS, using two 
different antibodies (Miltenyi Biotec) (Flynn et al. 1998). The first sorting can be performed with 
an antibody directed against target cells such as rods and some other tissues (e.g., with anti-
Kcnv2 antibody binding rods, cones, brain and barely the kidney) leading to enrichment of the 
corresponding cell populations. After the antibody is removed, a second sorting round could be 
applied, using an antibody also directed against target cells and other opposing tissues (e.g., 
anti-Lrp4 antibody binding rod photoreceptors and other tissues but not brain and only barely 
kidney) allowing further depletion of unwanted cell types. This approach should result in an 
enriched photoreceptor population but would not require such a stringent selection of antibodies 
that solely bind to photoreceptors. Notably, the observation that the generation of neural cells in 
culture is an efficient process and that the differentiation into cell types of other tissues is low or 
absent, makes a pull-down approach with two antibodies a suitable application to receive highly 
pure target cell fractions using MACS. In the future, gene profiling and identification of cell 
surface markers specific for transplantable cones will be important to define and generate tools 
for purifying and separating rod or cone photoreceptors for developing stringent cell 
replacement strategies, tackling specific retinal degenerative diseases, characterized by rod, 
cone, or combined cone and rod loss. 
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3 Reactive gliosis and enlarged subretinal graft 
distribution improve integration rates of 
transplanted photoreceptor precursors 
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3.1 Introduction 
 
Although the proof-of-concept of photoreceptor replacement approaches into different adult 
degeneration mouse models, mimicking human retinal degenerative diseases, has been 
demonstrated, several limitations remain, specifically in regard to the integration of donor 
photoreceptors into the host tissue as, their numbers following transplantation is still limited 
(Barber et al., 2013; Eberle et al., 2012, 2011; Pearson et al., 2012). First studies suggested 
that components of the host environment have significant influence on donor photoreceptor 
migration within the host tissue, including the OLM (Pearson et al., 2010), extra cellular matrix 
components and reactive gliosis (Barber et al., 2013). Indeed, disruption of the OLM, as 
appearing in Crb1rd8/rd8 mice or artificially created via the injection of small interfering ribonucleic 
acid (RNA) against the OLM tight junction protein zonula occludens 1, resulted in increased 
integration rates (Barber et al., 2013; Pearson et al., 2012, 2010). Furthermore, digestion of 
extra cellular matrix components like proteoglycans using chondroitinase ABC (Barber et al., 
2013; Pearson et al., 2012) or reduced gliosis reactivity by decreased expression of 
intermediate filaments like GFAP in Müller glia cells, were suggested to have positive effects on 
donor cell integration into the mouse retina (Barber et al., 2013). 
To further evaluate the influence of the host environment, we analyzed two conditions that might 
have considerable impact on photoreceptor integration into the mammalian retina: (1) as retinal 
degenerative diseases predominantly appear in aged patients, the integration rate of 
photoreceptors was compared following transplantation into mice of different ages, and (2) a 
rod-depleted mouse model (Mears et al. 2001), in which the ONL is solely composed out of 
cone and cone-like photoreceptors (Nrl -deficient mouse [Nrl-/-]) with temporally degeneration, 
rosette formation and a defective OLM. We observed increased integration rates in aged wild-
type and cone-only retinae and identified increased gliosis and higher distribution of 
transplanted cells in the subretinal space as factors for elevated donor photoreceptor 
integration. The following data are summarized in a manuscript, entitled “Reactive gliosis and 
enlarged subretinal graft distribution improve integration rates of transplanted photoreceptor 
 recursors”  authors: Kai Postel, Tiago Santos-Ferreira, Marius Ader), and submitted for 
publication. 
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3.2 Results 
3.2.1 Transplantation of photoreceptor precursors into aging mice 
 
To evaluate the influence of host age for integration, we transplanted CD73-based MACS-
enriched photoreceptors, derived from PN4 Nrl-EGFP mice, into the subretinal space of wild-
type mice at 8 weeks, 12 weeks, 0.5 years, 1 year and 1.5 years of age. In all evaluated 
conditions, transplanted cells were able to integrate into the ONL of recipients and developed 
into mature photoreceptors (Figure 15A [8 weeks], B [1 year], images not shown for 12 weeks, 
0.5 years and 1.5 years). The integrated cells expressed the pan-photoreceptor specific protein 
recoverin (Figure 15C) and the rod photoreceptor specific marker rhodopsin (Figure 15D, 
arrows) and formed inner (Figure 15D, asterisk) and outer segments, extending towards the 
RPE (Figure 15D, arrows). Moreover, synapses of transplanted cells were observed in the host 
OPL in close proximity to endogenous protein kinase C-alpha (PKCα)-positive rod bipolar cells 
(Figure 15E, arrow). The total number of integrated donor photoreceptors in the ONL per eye 
was quantified (Figure 15F) and revealed an increasing integration rate with aging of hosts, from 
2,041 ± 563 at 8 weeks; 3,581 ± 1,083 at 12 weeks; 4,198 ± 733 at 0.5 years; 5,876 ± 835 at 1 
year to up to 6,000 ± 783 at 1.5 years (ANOVA: *p<0.05). 
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Figure 15: The integration rate of subretinally transplanted rod photoreceptor cells increased with the age of 
host mice 
Transplanted cells, derived from four-day-old Nrl-EGFP mice, integrated into the retina of eight-week-old (A) and one-
year-old (B, C-E) mice and formed mature photoreceptors with inner segments (D, asterisk), expressed the pan-
photoreceptor marker recoverin (C, arrow), the rod marker rhodopsin in the outer segments (D, arrow) and formed 
synapses in the OPL (E, arrow). With increasing age of recipient animals, the integration rate of transplanted cells 
increased from 2,041 ± 563 in 8 week-old animals up to 6,000 ± 783 cells per retina in 1.5-year-old animals (F) (mean 
± SEM). DAPI: 4', 6-diamidino-2-phenylindole, EGFP: enhanced green fluorescent protein, INL: inner nuclear layer, 
IPL: inner plexiform layer, IS: inner segment, ONL: outer nuclear layer, OPL: outer plexiform layer, OS: outer 
seg ent, PKCα:  rotein kinase C-alpha, recov: recoverin, rho: rhodopsin, RGC: retinal ganglion cell layer. Scale bars 
in A, B: 50 µm, scale bars in D-F: 20 µm. ANOVA: *p < 0.05. n=number of eyes. 
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3.2.2 Increased integration of rod photoreceptors into Nrl-/- mice 
 
Transplantation experiments were conducted in 0.5 year-old Nrl-/- mice to analyze whether the 
numerical dominance of cones in a rod-depleted retina and the involved changes in the 
composition of the OLM influence rod photoreceptor integration rates. CD73-based MAC-sorted 
PN4 Nrl-EGFP photoreceptors integrated into the ONL of Nrl-/- mice (Figure 16A). Integrated 
photoreceptors, as well as cells remaining in the subretinal space, expressed mature 
photoreceptor markers like recoverin in the cell body (Figure 16B, arrows) and rhodopsin in the 
outer segment (Figure 16C, magnification C´, arrow). Donor cells also formed inner segments 
(Figure 16C, magnification C´, asterisk) and axonal terminals located in the OPL in close 
 roxi ity to endogenous PKCα-positive rod bipolar cells (Figure 16C, magnification C´´, arrow). 
Retinal areas without integrated cells (Figure 16D, D´, white box) displayed only cone-specific 
red/green opsin expression while rhodopsin-positivity was only observed in areas containing 
donor rod photoreceptors (Figure 16D, D´). The number of integrated cells per retina in Nrl-/- 
mice was quantified, resulting in a statistically significant three-fold increase when compared to 
age-matched wild-type animals (Figure 16E; 0.5 years; Nrl-/-: 12,334 ± 1,699, n=6; wild-type: 
4,198 ± 733, n=7; ***p < 0.001). 
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Figure 16: Transplanted cells integrated into the Nrl
-/-
 mouse retina in higher numbers than in wild-type hosts  
Enriched and transplanted rod photoreceptors integrated into the retina of Nrl
-/-
 mice (A), expressed the photoreceptor 
marker recoverin (B), and developed into morphological mature photoreceptors, containing inner segments (C, and 
magnification in C`, asterisk), rhodopsin-positive outer segments (C, and magnification in C´, arrow) and synapses 
located in the OPL (C, and magnification in C´´). Areas containing integrated cells showed rhodopsin-positivity and 
red/green opsin staining from endogenous cones, while areas without integrated cells displayed only red/green opsin 
expression (D, D´, white box). Quantification of integrated cells revealed a three-fold higher (12,334 ± 1,699 
cells/retina) integration in Nrl
-/-
 retinae than in age matched wild-type mice (4,198 ± 733 at 0.5 years, E) (mean ± 
SEM). DAPI: 4', 6-diamidino-2-phenylindole, EGFP: enhanced green fluorescent protein, INL: inner nuclear layer, IS: 
inner segment, Nrl
-/-
: neural retina leucine zipper knock out, ONL: outer nuclear layer, OPL: outer plexiform layer, OS: 
outer seg ent, PKCα:  rotein kinase C-alpha, recov: recoverin, RGC: retinal ganglion cell layer, r/g ops: red/green 
opsin, rho: rhodopsin, SRS: subretinal space, wt: wild-type. Scale bars in A, D, D´: 50 µm, scale bars in B, C: 20 µm. 
***p < 0.001. n=number of eyes. 
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3.2.3 Müller glia activation permits donor photoreceptor integration 
 
Activation of Müller glia cells upon retinal damage was reported to have negative effects on graft 
integration into the retina (Kinouchi et al. 2003; Barber et al. 2013). Due to ongoing inflammation 
in aged mice (Chen et al. 2010) and the presence of gliosis in Nrl-/- animals (Roger et al. 2012), 
we analyzed retinal gliosis after transplantation in young (8 weeks) and aged (1 year) wild-type 
mice and Nrl-/- animals (17 weeks) by immunohistochemistry for the gliosis marker GFAP. In 
non-transplanted eight-week-old wild-type animals, GFAP expression is restricted to astrocytes 
located in the RGC (Figure 17A). In one-year-old mice, further GFAP+ Müller glia fibers span 
through the retina from the RGC up to the OPL, indicating the association of gliosis to the aging 
process (Figure 17B). Notably, high levels of gliosis were observed throughout the retina of 
eight-week-old Nrl-/- animals, most likely caused by the transient degeneration process observed 
in this transgenic line (Figure 17C). After transplantation of CD73-enriched Nrl-EGFP 
photoreceptors into eight-week and one-year-old wild-type animals or Nrl-/- animals, no GFAP 
stress fibers were observed in the periphery of eight-week-old wild-type retinae (Figure 17D). In 
contrast, high GFAP levels were observed throughout the retina of one-year-old wild-type 
(Figure 17E) and Nrl-/- animals (Figure 17E). At the side of transplantation and cell integration, 
high gliosis was observed in the eight-week- (Figure 17G) and one-year-old (Figure 17H) wild-
type animals as well as Nrl-/- (Figure 17I) animals, indicating strong reactivity of Müller glia 
(Figure 17F, I). Interestingly, an increased integration rate of transplanted photoreceptors was 
observed in conditions with signs of elevated reactive gliosis, i.e. in aged wild-type and Nrl-/- 
mice.  
To further investigate this finding, the influence of induced GFAP expression on donor 
photoreceptor integration was analyzed. Therefore, active induction of gliosis was provoked by 
poking the retina two times in the vicinity of the retinal detachment, immediately after subretinal 
injection. This manipulation caused an increased GFAP expression at the transplantation site 
and accessorily in the retinal periphery of eight-week-old wild-type mice (Figure 17J, K). 
Interestingly, increased gliosis induced significantly elevated integration numbers into the host 
retinae (2,041 ± 563 in untreated retina vs. 3,807 ± 470 in poked retinae) after transplantation 
(Figure 17L). Taken together, the data suggest that the integration rate of transplanted cells can 
be influenced by modulating gliosis levels in the host retina. 
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Figure 17: Increased GFAP expression in aged wild-type and Nrl
-/-
 mice directly correlated with increased 
integration of transplanted cells 
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Untreated retinae of eight-week- (A) and one-year-old (B) wild-type animals displayed no GFAP expression, while 
Nrl
-/-
 retinae contained GFAP-positive stress fibers throughout the retina (C). After transplantation of CD73-enriched 
photoreceptors, no elevated GFAP expression was observed in the periphery of eight-week-old wild-type retinae (D), 
while GFAP-positive fibers span the whole retina of one-year-old wild-type (E) and Nrl
-/-
 (F) mice. In all three 
conditions, strong GFAP positivity was observed at the photoreceptor integration site (G, H, I). Additional perforation 
of the retina in the vicinity of the transplanted region in eight-week-old wild-type animals resulted in supplemental 
increased GFAP expression in the periphery (J) of the retina and almost doubled the integration rate per eye, from 
2,041 ± 563 (without perforation) to 3,807 ± 470 (with perforation) (mean ± SEM) (L). DAPI: 4', 6-diamidino-2-
phenylindole, EGFP: enhanced green fluorescent protein, GFAP: glial fibrilary acidic protein, INL: inner nuclear layer, 
IPL: inner plexiform layer, Nrl
-/-
: neural retina leucine zipper knock out, ONL: outer nuclear layer, OPL: outer plexiform 
layer, RGC: retinal ganglion cell layer, wt: wild-type. Scale bars: 50 µm. *p<0.05. n=number of eyes. 
 
3.2.4 Increased area coverage by donor photoreceptors in Nrl-/- host retinae 
 
Nrl-/- animals contained three-fold more integrated donor photoreceptors than wild-type mice 
and beside elevated GFAP expression, we observed that donor photoreceptors covered 
extended areas of the retina when compared to wild-type hosts. Therefore, the coverage area, 
i.e. the distribution of donor cells in the retinae of flat-mounted Nrl-/- and wild-type mice, was 
quantified two weeks after transplantation (Figure 18). While in the eight-week (Figure 18A-A´´, 
D) and one-year-old (Figure 18B-B´´, D) wild-type animals only 8.4 % ± 0.6 % (mean ± SEM, 
n=4) or 7.7 % ± 0.53 % (mean ± SEM, n=9) of the retina contained transplanted cells, 25.6 % ± 
2.5 % (mean ± SEM, n=4) of the retina of age-matched Nrl-/- mice were populated with 
transplanted cells (Figure 18C-C´´, D). 
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Figure 18: Transplanted cells covered a 
significantly larger area in rod-depleted 
Nrl
-/-
 mice than in young and aged wild-
type animals  
Subretinal transplanted cells covered 8.4 % 
± 0.6 % in eight-week (A-A’’ and D) and 7 7 
% ± 0.53 % in one-year-old (B-B’’ and D) 
wild-type animals. In contrast, a significantly 
higher area (25.6 % ± 2.5 %) was coated in 
Nrl
-/-
 mice (C-C’’ and D)  Many integrated 
cells were visible in all conditions (enlarged 
views A´, A´´, B´, B´´, C´, C´´, asterisk), but 
in one-year-old wild-type and eight-week-
old Nrl
-/-
 animals, many cells remained in 
the subretinal space (B´, B´´, C´, C´´, 
arrows). DAPI: 4', 6-diamidino-2-
phenylindole, EGFP: enhanced green 
fluorescent protein, Nrl
-/-
: neural retina 
leucine zipper knock out, w: weeks, wt: 
wild-type. Scale bars in A, B, C, E, E´: 500 
µm, scale bars in A´, B´, C´: 100 µm, scale 
bars in A´´, B´´, C´´: 200 µm. ***p < 0.001. 
n=number of eyes. 
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3.3 Discussion 
 
The loss of photoreceptors in retinal dystrophies represents the main cause for vision 
impairment and blindness. Whereas inherited forms of degeneration like RP are often initiated 
during young adulthood, the development of clinical symptoms often takes years up to decades. 
Furthermore, AMD is the leading cause for blindness in people older than 50 years in 
industrialized countries (chapter 1.3). Beside diverse other factors, multiple genetic defects 
influence the degeneration process, therefore generating varying disease environments. 
Furthermore, most retinal diseases in humans primarily affect either the cone dominated macula 
or the rod enriched periphery. Thus, the condition of the host tissue, including age, cell 
composition or degeneration phase, might represent crucial variables that have to be taken into 
account when therapeutic interventions, like cell transplantation approaches, are developed. 
Here, we evaluated the role of age of recipient mice in the integration efficiency of transplanted 
donor photoreceptors and observed that the retinae of aged wild-type mice are more permissive 
for integration of transplanted photoreceptors. Furthermore, we discovered that also in Nrl-/- 
mice, i.e. a rod-depleted mouse model in which the retina is solely composed out of cone and 
cone-like photoreceptors, the integration rate is three-fold higher than in age-matched wild-type 
animals.  
One factor, that was recently described to have an important effect on cell integration, is 
reactive gliosis (Kinouchi et al. 2003; Barber et al. 2013). Gliosis in the retina can be induced by 
retinal degeneration (Barber et al. 2013; Bartsch et al. 2013), damage/injury (Lamba et al. 
2009), inflammation (Dinet et al. 2012), or aging (Kim et al. 2004; Chen et al. 2010) and is 
characterized by accumulation of chondroitin sulfate proteoglycans and activation of Müller glia 
cells, expressing the intermediate filament GFAP beside increased amounts of neurotrophic 
factors, cytokines or growth factors (BDNF, CNTF, bFGF, IGF-1, NGF, neurotrophins-3 and -4, 
GDNF,  IF TNFα , MCP-1, IL-8 and -1, Cxcl16, CCL-2 and others) (Bringmann et al. 2009; 
Lebrun-Julien et al. 2009).  
Indeed, increased gliosis, marked by GFAP-expression of Müller glia, was observed in the 
retina of Nrl-/- mice older than two month (Roger et al. 2012) and in one and 1.5 year-old wild-
type mice (this study). Consistent with our observations are reports, which demonstrated 
elevated expression of genes related to stress/injury response and increased microglia and 
complement activation in aged wild-type mouse and rat retinae (Kim et al. 2004; Chen et al. 
2010). Interestingly, transplanted photoreceptors preferably integrated at sites of increased 
GFAP expression, as in aged wild-type and Nrl-/- mice, suggesting that reactive gliosis provides 
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a permissive environment for photoreceptor integration. This hypothesis is further emphasized 
by the observation that induced reactive gliosis, by injuring the retina of wild-type mice, also 
resulted in increased integration rates. Previous studies indicated a guiding function of glia cells 
in brain and retina during development, which might also help transplanted cells to integrate 
(Meller and Tetzlaff 1976). Furthermore, integration of vitreally transplanted hippocampal stem 
cells was shown to be dependent on injuring the retina and was associated with up-regulation of 
GFAP and nestin in Müller glia processes (Nishida et al. 2000). Despite elevated GFAP 
expression, activation of Müller glia cells is associated with release of cytokines, whose 
expression was also already shown in aged retinae (Chen et al. 2010). Chemokines like CCL2, 
CCL3, CCL8 and CCL12 are released due to inflammation processes associated with aging, 
which in turn recruit cells from the immune system, like macrophages and lymphocytes, to the 
affected region (Chen et al. 2010). Moreover, the expression of C-X-C chemokine receptor type 
4 by human photoreceptors was already shown (Bhutto et al. 2006), supporting the hypothesis 
that transplanted photoreceptors might also up-regulate other chemokine receptors and react to 
chemokine gradients, produced by activated Müller glia cells, finally allowing increased 
integration in mice with elevated gliosis. Notably, our findings are in contrast to recent studies, 
suggesting a correlation of reduced integration of transplanted photoreceptors and increased 
gliosis, characterized by GFAP expression and chondroitin sulfate proteoglycan deposition in 
retinal degeneration models (Gnat1-/-, rho-/- mice) (Barber et al. 2013). Remarkably, the authors 
did not observe higher GFAP expression in one-year-old wild-type animals and also no 
increased integration of transplanted rod photoreceptors at this age. Although the removal of 
proteoglycan deposits via injection of chondroitinase ABC led to unequivocal higher integration 
rates, a direct evidence for an inhibiting role of GFAP expression for donor cell integration was 
not provided (Barber et al. 2013). Notably, Prph2rd2/rd2 mice also had elevated gliosis, but 
showed no differences in integration rates (Barber et al. 2013). 
Maintenance of OLM integrity is crucial for a healthy retina and its disruption results in 
photoreceptor degeneration (Mehalow et al. 2003; Stuck et al. 2012; Alves et al. 2013). 
Additionally, disruption of the OLM also might support increased integration numbers of 
photoreceptors following transplantation (Pearson et al. 2010; Pearson et al. 2012; Barber et al. 
2013). In the Nrl-/- retina, the formation of rosettes is caused by the loss of rod photoreceptors 
and associated with defects in the OLM (Stuck et al. 2012). After three to four weeks, rosettes 
are mature and localized within the ONL and the OLM appears intact again. Although the 
reasons for an association between loss of rods and defects in OLM formation is not well 
investigated, cones and rods might contribute with different components to the formation of the 
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OLM, causing structural changes (Stuck et al. 2012) which might reduce OLM stability and help 
transplanted cells to integrate. This is consistent with findings demonstrating increased 
integration due to OLM changes in the degeneration mouse model Crbrd8/rd8, or upon active 
disruption of the OLM via small interfering RNA injection (Pearson et al. 2010; Barber et al. 
2013). Although we did not observe changes in the integrity of the OLM via stainings for F-actin 
with phalloidin in aged mice and Nrl-/- animals (data not shown), changed OLM composition in 
Nrl-/- mice and the aging process in wild-type animals might also influence OLM structure and 
thus integration rates. 
Another important factor that might support a higher integration rate of transplanted cells in Nrl-/- 
mice is retinal detachment, possibly caused by decreased stability of outer segment – RPE 
contacts (Roger et al. 2012). We observed that after transplantation into Nrl-/- mice a more than 
two-fold larger area of the retina was covered by integrated cells than in young and also aged 
wild-type mice. Interestingly, a recent study demonstrated significant higher integration rates 
following pre-detachment of the host retina with injections of phosphate-buffered saline (PBS) or 
double cell injections without evaluating the underlying mechanism(s) (Pearson et al. 2012). 
Based on our findings, increased reactive gliosis combined with wider distribution of donor 
photoreceptors in the subretinal space, might be the cause for the described effect. 
Finally, increased integration in Nrl-/- mice might also be influenced by reduced outer/inner 
segment and cell body packing in the subretinal space and ONL, respectively. Preliminary data 
suggest that four- to six-week-old Nrl-/- mice have 40 % less cells in the ONL than wild-type 
animals (Daniele et al. 2005). Such reduced cell number might also result in a lower density 
within the ONL and thus give transplanted cells more space to integrate. 
In summary, our results suggest that reactive gliosis, identified by expression of GFAP in Müller 
glia, represents a permissive environment for the integration of transplanted photoreceptors and 
promote donor cells to migrate into the host ONL. Additionally, further increased integration in 
gliotic Nrl-/- mice might be the result of a broader distribution of transplanted cells in the 
subretinal space accompanied by reduced density of cells in the ONL and defects in the OLM. 
In conclusion, the integration process of transplanted photoreceptors into host retinae appears 
highly complex and the exact cellular and molecular mechanisms that influence donor cell 
migration have to be further systematically investigated in more detail. Increasing knowledge 
about the host influence might help developing specific methods to modify recipient retinae for 
increasing integration rates of transplanted photoreceptors, allowing restoration of visual 
function. Such defined regimes represent important prerequisites for the development of cell-
based strategies towards clinical applications, aiming to replace degenerated photoreceptors.  
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4 Transplantation of enriched rat 
photoreceptors into mice and rats 
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4.1 Introduction 
 
Beside retinal gliosis or OLM integrity, the type of host as well as donor species, carrying retinae 
with different abilities, might have major impact on the success of retinal cell replacement. 
Additionally, gaining experience in retinal cell replacement in other species than mice 
represents an important prerequisite for the application of this approach in a clinical setting. 
However, most important steps in retinal cell replacement, including successful integration or 
the regain of functionality, were achieved in mice, leaving other species not well understood. 
Few studies evaluated transplantation approaches in rats or pigs, confirming the immune 
privileged status of the eye and reporting some neuroprotective effects of grafts, derived from 
different sources (Qiu et al. 2005; Gamm et al. 2007; Inoue et al. 2007; Klassen et al. 2007; 
Seiler et al. 2008; Yang et al. 2010a; Yang et al. 2010b; Klassen et al. 2012).  
With the aim to rescue the retina during its degeneration in rats lacking proper RPE function 
(Royal College of Surgeon rats), human neural progenitor cells (Gamm et al. 2007) or mouse 
bone marrow mesenchymal stem cells (Inoue et al. 2007) were transplanted subretinally. 
Transplanted cells survived for prolonged time (up to five month) in host retinae, migrated and 
secreted growth factors, resulting in neuroprotective effects slowing down the degeneration 
process. Despite neuroprotection, also the immune privileged status of the eye was proven, as 
no rejection was observed. Also the transplantation of photoreceptor sheets or whole retinal 
sheets, derived from PN8 rats, into P23H rats (rhodopsin mutation leading to retinal thinning) 
had some protective effect for endogenous cones rather than a replacing function (Yang et al. 
2010b). The degeneration process was slowed down, as the morphology and number of 
endogenous cones was preserved, but a functional integration of grafted cells into the remaining 
host tissue as well as photoreceptors morphology within the graft was not observed, although 
the cells expressed the photoreceptor marker rhodopsin (Yang et al. 2010b).  
Other studies directly aimed to replace degenerated cells in rats mimicking human retinal 
dystrophies (Qiu et al. 2005; Seiler et al. 2008; Yang et al. 2010a). Qiu et al. (2005) isolated 
retinal progenitors from E17 rats, cultured them for several days and transplanted them into the 
subretinal space of degenerating rat models (rhodopsin mutations S334ter-3 and S334ter-5). 
Although photoreceptor marker expression was in vitro only weak, cells displayed strong 
rhodopsin- and recoverin-positivity after transplantation. However, differentiation into 
morphological mature photoreceptors or connectivity to endogenous tissue was not observed 
(Qiu et al. 2005). More recently, whole retinal sheets derived from fetal rat donors were 
transplanted into the subretinal space of degenerating rats (Seiler et al. 2008; Yang et al. 
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2010a). The grafts appeared intact, containing an ONL with rhodopsin-positive outer segments, 
INL and IPL. Nevertheless, it is highly disputable whether transplanted photoreceptors or bipolar 
cells, arranged in an intact retinal sheet and localized on top of the remaining endogenous INL 
and RGC, are able to establish synaptic connections with endogenous ganglion cells. However, 
authors suggested restoration of visual function (Seiler et al. 2008).  
Anyway, the isolation of photoreceptors from rat retinae at PN4, an age that was in mouse 
proven to be optimal for integration, their (FACS or MACS-mediated) enrichment and 
subsequent transplantation into the subretinal space of recipients to investigate their integration 
capacity, remains to be analyzed. 
Beside rats, also pigs were used for transplantation experiments into the retina (Klassen et al. 
2007; Klassen et al. 2012). Retinal cells from foetal fluorochrome expressing pigs at 60 days of 
gestation were collected, cultured and differentiated into photoreceptor-protein expressing cells 
(recoverin and rhodopsin). They were transplanted into the retina of four-month-old pigs and 
survived there up to five weeks. Grafted cells expressed photoreceptor markers like transducin, 
recoverin and rhodopsin and some single cells formed small extensions towards the INL and 
IPL of the host. Although the expression of photoreceptor markers and a long survival of 
transplanted cells in the retina of wild-type (Klassen et al. 2007) as well as degenerating 
(Klassen et al. 2012) pigs was shown, the differentiation into morphological mature 
photoreceptors, located in the ONL of the hosts, was not reported. Additionally, evidence for a 
connection to the host secondary neurons via synapses as well as the formation of outer-or 
inner segments, indicating functionality of donor photoreceptors, was not provided. 
Although sufficient functionality and connectivity to endogenous cells was not demonstrated 
until 2012 in mice (Pearson et al. 2012; Barber et al. 2013; Singh et al. 2013), first clinical trials 
were already performed in human patients suffering from RP or AMD in the 1990ies. Human 
fetal (14- to 16-week-old) and adult retinal tissue was transplanted into the retina of RP or AMD 
patients and demonstrated the acceptance of grafted tissue in the human eye for several 
months, providing first evidence for safety of such transplantation procedure (Kaplan et al. 1997; 
Das et al. 1999; Humayun et al. 2000; Radtke et al. 2004; Radtke et al. 2008). Interestingly, 
some groups reported slightly improved vision in patients within the first month after 
transplantation, but also its disappearance after some time (three to 13 month) in most cases 
(Humayun et al. 2000; Radtke et al. 2008). However, whether the observed improvements were 
caused by the participation of grafted tissue to the visual process or whether the transplants 
contributed to a short term functional increase via neurotrophic effects, as also reported from 
other transplanted cell populations (see above), was not investigated in detail (Eveleth 2013). 
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In summary, studies in rats, pigs or humans confirmed that the eye is an immune privileged 
organ and that transplanted cells are not rejected, independent form donor or host species. 
Trophic effects of transplanted cells or whole retinae should not be underestimated and seem to 
slow down the degeneration of the retina. Sufficient functional recovery was up to now only 
achieved after transplantation in mice, indicating that the strategy applied there, including 
enrichment and transplantation of young single photoreceptors, might also be successful in 
other species and an alternative to transplantation of whole retinae on top of the endogenous 
INL. Notably, RP or AMD are usually diagnosed when some vision in patients is left, indicating 
that also cells of the ONL are still present. Thus, transplanting single cells, that migrate into the 
remaining ONL rather than inserting a whole new retina on top of existing cells, might represent 
currently a promising strategy for the treatment of retinal degenerative diseases. 
With the aim to proof the concept of retinal cell replacement by single cells in other species then 
mice, we translated our established protocol of CD73-based photoreceptor enrichment and 
subretinal transplantation (Eberle et al. 2011; Eberle et al. 2012; Postel et al. 2013) to the rat 
model. 
 
4.2 Results 
4.2.1 MAC-sorting of rat cells 
 
Experiments in mice demonstrated the importance of photoreceptor enrichment prior to their 
subretinal transplantation, to receive increased integration rates and to reduce the risk of tumor 
formation (Lakowski et al. 2010; Eberle et al. 2011; Lakowski et al. 2011; Eberle et al. 2012; 
Barber et al. 2013; Gonzalez-Cordero et al. 2013). Thus, the previously established CD73-
dependend MACS procedure for the specific enrichment of mouse photoreceptors (chapter 
2.2.3; Eberle et al. [2011]) was translated to the rat, aiming to receive enriched rat 
photoreceptor populations for subsequent transplantations into the subretinal space of 
recipients. We isolated retinae of PN4-6 dark agouti (DA/HanRj) rats and performed MACS with 
rat-specific anti-CD73 antibody. We evaluated successful binding with secondary APC-
conjugated antibody and analyzed cell populations by flow cytometry (Figure 19). Antibody 
titration revealed most specific antibody binding and highest purity with a concentration of 5 
µg/ml anti-CD73 antibody. Initially, 37 % ± 12 % of rat retinal cells expressed CD73 (Figure 19A 
[red curve, APC+], B [unsorted]). CD73-mediated MACS enabled enrichment of CD73-positive 
photoreceptors with a purity of 93 % ± 2 % (Figure 19A [blue curve, APC+], B [CD73+ sorted]). 
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Results were confirmed with RT-PCR, demonstrating high CD73 and rhodopsin expression in 
the CD73-enriched population (CD73+ sorted) in comparison to input (unsorted) and flow-
through (CD73- sorted) populations (Figure 19C). 
 
 
Figure 19: CD73-mediated MACS of PN4-6 rat retinal cells 
In unsorted PN4-6 dissociated rat retinae, 37 % ± 12 % of all cells expressed CD73, labeled by secondary APC-
antibody binding, and thus represented prospective photoreceptors (A [red curve, APC+], B [unsorted]). After 
enrichment by CD73-mediated MACS, 93 % ± 2 % of cells expressed CD73, representing a highly enriched 
population (A [blue curve, APC+], B [CD73+ sorted]). The CD73-negative sorted fraction contained 28 % ± 12 % 
CD73-expressing cells (A [green curve], B [CD73- sorted]). RT-PCR confirmed success of CD73-mediated 
photoreceptor enrichment (C). While CD73 and the rod photoreceptor marker rhodopsin (rho) were higher expressed 
in the CD73-positive sorted populations (CD73+ sorted) and to a lesser extend in the unsorted fraction (unsorted), it 
was strongly reduced in the CD73-negative sorted (CD73- sorted) population (C). APC: allophycocyanin, rho: 
rhodopsin. ANOVA: **p < 0.01. 
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4.2.2 Transplantation of enriched rat photoreceptors into mouse and rat recipients 
 
For the identification of rat cells after their transplantation into the retinae of wild-type hosts, we 
used a transgenic rat reporter line engineered by Michael Bader (Max-Delbrück-Centrum für 
molekulare Medizin, Berlin). These rats expressed a construct containing the ubiquitin promoter 
driving a microRNA against CD8 and a GFP tag (named L9021 MirTPH2 rat). Due to its easy 
accessibility and the fact that the microRNA against CD8 should only harm T-lymphocytes and 
thus not influence photoreceptors, we used this rat line as a source for donor cells in 
transplantation experiments. Further characterization illustrated that L9021 MirTPH2 rats 
expressed the photoreceptor marker recoverin in the developing (Figure 20A) and mature 
(Figure 20D) ONL as well as CD73 (Figure 20B, E). GFP is expressed in a mosaic manner in 
PN4 and adult rats, suggesting the identification of a considerable number of donor 
photoreceptors after transplantation (Figure 20C, F). 
 
 
Figure 20: Sections of GFP expressing L9021 MirTPH2 rat retinae, used as transplantation donors 
CD73 is co-localized with recoverin in PN4 (A, B) and adult (D, E) ONL in rats and thus confirming its expression in 
young and adult photoreceptors. GFP, under the control of ubiquitin promoter, is expressed throughout the retina in a 
mosaic manner (C, F), allowing identification of rat photoreceptors following transplantation. DAPI: 4', 6-diamidino-2-
phenylindole, GFP: green fluorescent protein, ONL: outer nuclear layer, NBL: neuroblast layer, INL: inner nuclear 
layer, RGC: retinal ganglion cell layer. Scale bars: 50 µm. 
 
For control experiments, CD73-enriched Nrl-EGFP mouse cells were transplanted into the 
subretinal space of wild-type mice (Figure 21A) and rats (Figure 21B). Here, many cells 
survived in the subretinal space of both, mice and rats. While robust integration of donor 
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photoreceptors into the ONL of mice (Figure 21A) and development into morphological mature 
photoreceptors with cell bodies (white arrow), inner segments (yellow arrow), outer segments 
(blue arrow) and synapses (asterisk) was observed, only few cells integrated into the rat ONL, 
forming photoreceptors with immature morphology, lacking synaptic connections or outer 
segments (Figure 21B, smaller image). After transplantation of CD73-enriched rat cells into wild-
type mice (Figure 21C) and rats (Figure 21D), many cells survived two weeks in the subretinal 
space. Only few integrated cells were identified in the mouse retina, generating a mature 
photoreceptor morphology with synapses (asterisk), inner segments (yellow arrow) and outer 
segments (blue arrow), while in the rat even less cells were located in the ONL, presenting 
immature morphology (Figure 21D). 
 
 
Figure 21: Transplantation of CD73-enriched rat and mouse photoreceptors into the subretinal space of wild-
type rats and mice 
Localization of MACS-enriched mouse photoreceptors, two weeks following transplantation into the subretinal space 
of mice (A) or rats (B). Many cells integrated into the ONL of mice (A) and differentiated into morphological mature 
photoreceptors containing cell bodies (white arrow), inner segments (yellow arrow), outer segments (blue arrow) and 
synapses (asterisk). In contrast, only few donor cells integrated into the ONL of rats and formed inner segments (B). 
Enriched and transplanted rat photoreceptors also survived for up to two weeks in the subretinal space of mice (C) 
and rats (D). In mice (C), some rat cells integrated into the ONL and developed into morphological mature 
photoreceptors, while in the rat retina (D), only few single cells were detected, appearing immature. DAPI: 4', 6-
diamidino-2-phenylindole, GFP: green fluorescent protein, ONL: outer nuclear layer, INL: inner nuclear layer. 
Attached small images show enlarged views. Scale bars: 50 µm. 
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To confirm these results, we additionally labeled retinal cells of DA/HanRj rats with 5-ethynyl-2´-
deoxyuridine (EdU). EdU, as a nucleoside analogue of thymidine, is incorporated into the DNA 
during mitosis and can be detected via a click reaction with a fluorescent dye (Alexa 647). 
Following injection of EdU during retinogenesis, retinal cells of PN4 rats displayed robust 
labeling (Figure 22A) that was still present 14 days later at PN18 (Figure 22B). Staining in PN4 
rats was quantified by flow cytometry and revealed EdU-positivity of 40% of all retinal cells as 
well as CD73-enriched cells (data not shown). Subsequently, labeled photoreceptors were 
enriched using MACS and transplanted into the subretinal space of adult rats (21-weeks old) 
and mice (eight-weeks-old). Considerable numbers of transplanted photoreceptors were 
identified after two weeks in the subretinal space of wild-type rats (Figure 22C) and mice (Figure 
22D). While in rats no integration into the ONL was observed, in mice some cells were visible in 
the ONL (Figure 22D, enlarged view), confirming results received from transplantations of cells 
derived from L9021 MirTPH2 rats, suggesting limited integration capacity of rat cells in the 
mouse as well as the rat retina. 
 
 
Figure 22: EdU-labeling of rat cells and transplantation into rats and mice 
Systemic injection of EdU at E20, PN1 and PN3 labeled many cells in the retina of PN4 (A) rats that were still 
detectable 14 days later in the PN18 retina (B). EdU-positive transplanted cells survived 14 days in the subretinal 
space of rats (C) and mice (D), but did not integrate into the ONL of rats, while few single cells were detected in the 
ONL of mice (D, enlarged view). DAPI: 4', 6-diamidino-2-phenylindole, EdU: 5-ethynyl-2´-deoxyuridine, INL: inner 
nuclear layer, NBL: neuroblast layer, ONL: outer nuclear layer, PN: postnatal day, RGC: retinal ganglion cell layer, 
SRS: subretinal space. Scale bars: 50 µm. 
 
To enhance integration capacity of transplanted rat photoreceptors into the rat retina, 
supplemental experiments were performed containing modified conditions. Previous studies in 
mice indicated that the developmental stage of donor photoreceptors is crucial for sufficient 
integration rates (MacLaren et al. 2006; Bartsch et al. 2008; Lakowski et al. 2010). Therefore, 
we performed transplantations with CD73-enriched photoreceptors, isolated from PN1 up to 
PN6 rats. Furthermore, we increased the transplantation volume from two up to four microliter, 
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containing up to 800,000 cells, and treated recipient animals with cyclosporine A for immune 
system suppression (data not shown). Since double injections were already reported to increase 
integration rates of transplanted cells in mice (Pearson et al. 2012), we injected also two times 
two microliter cell suspension nasal and temporal, respectively, into the subretinal space of rats. 
However, all attempts to support integration of transplanted rat photoreceptors into the rat retina 
did not result in enhanced integration rates. 
 
4.3 Discussion 
 
Despite initial transplantation studies into rats (Qiu et al. 2005; Gamm et al. 2007; Inoue et al. 
2007; Seiler et al. 2008; Yang et al. 2010a; Yang et al. 2010b), pigs (Klassen et al. 2007; 
Klassen et al. 2012) or humans (Kaplan et al. 1997; Das et al. 1999; Humayun et al. 2000; 
Radtke et al. 2004; Radtke et al. 2008), utilizing human neural progenitor cells (Gamm et al. 
2007), mouse bone marrow mesenchymal stem cells (Inoue et al. 2007), rat photoreceptor- 
(Yang et al. 2010b) as well as retinal sheets (Qiu et al. 2005; Seiler et al. 2008; Yang et al. 
2010a; Yang et al. 2010b) or human fetal retinal sheets (Kaplan et al. 1997; Das et al. 1999; 
Humayun et al. 2000; Radtke et al. 2004; Radtke et al. 2008) as donor tissue, unequivocal 
experiments demonstrating mature photoreceptor morphology, synaptic connectivity or function 
of donor cells were only performed in mice (chapter 1.5). 
Here, we used our knowledge of enriching primary mouse rod photoreceptors with CD73-based 
MACS and their subsequent transplantation into recipient mice (Eberle et al. 2011; Eberle et al. 
2012; Postel et al. 2013) and applied this technique to the rat model. We successfully enriched 
photoreceptors derived from PN4 transgenic rats with CD73-mediated MACS and confirmed 
these results by RT-PCR. Then, we transplanted these enriched photoreceptors into the 
subretinal space of adult wild-type rats or mice. Isolated and enriched rat photoreceptors 
survived in the subretinal space of both species for up to two weeks, confirming the immune 
privileged status of the eye. However, only few rat photoreceptors integrated into the ONL of 
mice and exhibited mature photoreceptor morphology, and even less cells were found in the rat 
ONL, appearing immature and lacking photoreceptor characteristics. After transplantation of 
enriched primary mouse photoreceptors into the rat retina, we also observed survival of cells, 
but also here, only some cells integrated into the host ONL and displayed photoreceptor 
morphology. 
Reduced integration after transplantation of mouse cells into the rat retina and vice versa may 
be explained by species incompatibilities. In contrast, missing integration ability of rat 
60 
 
photoreceptors into the rat retina is unexpected and antithetic to former mouse relevant studies 
(chapter 1.5). Reasons for this finding could be manifold and are subject of further 
investigations. Age of donor animals, retinal gliosis or cytokine release were proven to have 
important impact on cell integration in mice and thus might play crucial roles in rats as well. 
Studies indicate that retinal development and cell maturation in rats and mice happens 
temporally similar. First rod photoreceptors are born in rats as well as in mice at E13 to E16 
(Carter-Dawson and LaVail 1979; Young 1985) and reach their generation peak from PN1 to 
PN4. This age represents the developmental stage containing most young postmitotic 
photoreceptors that are known to have the optimal age for integration in mice after subretinal 
transplantation (MacLaren et al. 2006; Bartsch et al. 2008; Lakowski et al. 2010). Thus, we also 
used rat cells of four-day-old animals for transplantations into mice and rats, but did not observe 
sufficient integration. Also transplantation of PN1 to PN6 rat cells, covering a wider 
developmental window, did not change the outcome, indicating that the age might not be the 
crucial factor hindering cells from integration. Retinal gliosis, as indicated previously, is also 
suggested to have major impact on integration rates of transplanted photoreceptors in mice 
(chapter 3). Equivalent to mice, injuries of the rat retina or its degeneration, appearing e.g. in the 
Royal College of Surgeon rats, led to Müller glia cell activation characterized by GFAP 
expressing fibers extending throughout the retina (Huo et al. 2011). Similar to mice, rat Müller 
glia cells might release cytokines, chemokines and growth factors, helping neurons to survive. 
Although the underlying mechanisms are not investigated jet and the results are contradictory 
(Kinouchi et al. 2003; Barber et al. 2013, our study), the influence of retinal gliosis should be 
further investigated and experiments increasing gliosis (as described in chapter 3.2.3) as well as 
its inhibition (Kinouchi et al. 2003) should be carried out in rat hosts. 
Retinal cell replacement represents a promising treatment option for degenerative diseases like 
RP or AMD and thus reached the focus of scientific research several years ago. Although 
impressive progress was achieved during that time, the molecular mechanisms underlying the 
process of integration are still insufficiently investigated. Most successful studies were carried 
out in the mouse retina, luckily representing a permissive environment for cell integration. 
However, here we demonstrated that photoreceptors, derived from postnatal rats, do not 
sufficiently integrate into the rat retina following subretinal transplantation. Hence, these results 
open up the question whether the lack of photoreceptor integration in rats is just one exception, 
or might also occur in humans and therefore, should be taken into consideration for a future 
clinical setting. Based on this perspective, further investigation should be carried out using 
different animal models and investigating potential reasons for this finding. Despite retinal 
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gliosis, chemokine release, retinal composition or stiffness, other factors might be different 
between rats and mice and thus hinder transplanted cells from integration. Direct comparison 
between mouse and rat retinal cells, e.g. regarding gene expression, gliosis or cytokine release, 
might give more insight into the underlying mechanisms and might also give important hints for 
successful utilization of retinal cell replacement in patient treatment. 
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5 Conclusion and future perspectives 
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Vision impairment and blindness are major concerns in modern civilizations and importance will 
even increase with elevated age of the populations within next years. Multiple genetic defects 
and other factors influence the degeneration process and generate varying disease 
environments that have to be taken into consideration, when therapeutic interventions are 
developed. Several promising approaches like the epi-or subretinal implantation of electronic 
devices (da Cruz et al. 2013; Dorn et al. 2013; Stingl et al. 2013) or gene therapy for single 
diseased genes (Bainbridge et al. 2008; Maguire et al. 2009) were developed in the last years. 
Amongst them, the replacement of degenerated photoreceptors by transplantation of cells 
derived from ES or iPS cultures might be a general auspicious approach for the treatment of RP 
or AMD. Within the last years, studies demonstrated the isolation and specific enrichment of 
primary photoreceptors (MacLaren et al. 2006; Bartsch et al. 2008; Lakowski et al. 2010; 
Pearson et al. 2010; Eberle et al. 2011; Eberle et al. 2012; Pearson et al. 2012; Barber et al. 
2013) as well as the generation of photoreceptors derived from iPS (Meyer et al. 2009; Lamba 
et al. 2010) or ES cultures (Eiraku and Sasai 2012; Nakano et al. 2012; Gonzalez-Cordero et al. 
2013), the subretinal transplantation and functional integration of photoreceptors into wild-type 
as well as diseased mouse retinae and also the recovery of some visual function (Pearson et al. 
2012; Barber et al. 2013) upon photoreceptor replacement. 
In the work presented here, we identified cell surface markers being specific for young 
transplantable photoreceptors (Postel et al. 2013) and used CD73 for cell surface dependent 
photoreceptor enrichment by MACS, a method avoiding genetic modification of target cells 
(Eberle et al. 2011). We demonstrated that photoreceptors, enriched by this method, integrated 
in significant higher numbers into the host retina than unsorted populations. Further markers like 
Kcnv2, Cnga1 or Cacna2d4 were also identified as photoreceptor specific, but extracellular 
binding antibodies still need to be generated to prove their usefulness for photoreceptor 
enrichment prior to transplantation. Next steps should now involve the enrichment of 
photoreceptors derived from ES or iPS cell cultures and the transplantation of highly pure 
fractions into recipient retinae. Given, that AMD represents a disease with cone degeneration, 
further experiments should focus on the identification of cell surface markers specific for cone 
photoreceptors, allowing also their specific enrichment and subsequent transplantation. 
We further demonstrated that the host environment plays crucial roles for the successful 
integration of transplanted cells (Kai Postel, Tiago Santos-Ferreira, Marius Ader., submitted for 
publication). Although the exact mechanisms are not clarified yet, we suppose that increased 
retinal gliosis, occurring in aging mice or the rod-depleted Nrl-/- mouse, enhances photoreceptor 
integration. The effect of retinal gliosis is controversially discussed and therefore the exact 
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involvement of cytokine or chemokine release, the guiding function of GFAP-expressing fibers 
or the formation of the glial scar in retinal cell integration have to be investigated in more detail 
in further studies. Thus, experiments using GFAP-depleted (Kinouchi et al. 2003) mice or 
models showing increased gliosis (our study) might give more insight into the process. Besides 
retinal gliosis, subretinal distribution of transplanted cells, integrity of the OLM or retinal 
composition were identified as possible effectors for graft integration. These factors might form 
starting points for further understanding of the influence of host tissue for retinal cell integration 
and furthermore, offer options for host retina modulation, to receive increased integration rates. 
Finally, the successful cell transplantation approach could not be translated from mice to rats. 
Although young rat photoreceptors were effectively enriched via CD73-based MACS, cells did 
not integrate into the rat retina after transplantation and lacked the development into 
morphological mature photoreceptors. The reasons for this observation might be manifold and 
should be further investigated, because it also induces sorrows regarding cell replacement in 
the human retina. Direct comparisons with mice, regarding cytokine or chemokine release, cell 
adhesion, migratory proteins, OLM integrity or retinal density might bring new insight into the 
requirements for successful transplantation. Furthermore, the translation of cell replacement 
approaches towards a clinical application in a more promising way than reported previously 
(Kaplan et al. 1997; Das et al. 1999; Humayun et al. 2000; Radtke et al. 2004; Radtke et al. 
2008) might also require further understanding of cellular integration mechanisms. Retinal 
explants, derived from deceased human retina donors, might open up new possibilities to 
receive this understanding. In combination with the option to derive photoreceptors from human 
ES or iPS cells, a model for ex vitro transplantation in human tissue could be developed, 
allowing the investigation of the integration capacity of photoreceptors in human tissue. 
 
Although further knowledge about the integration mechanisms of transplanted cells is still 
required, the progress in the past years was capital, suggesting further advance in the field and 
the development of a suitable therapy for the treatment of dystrophic retinal diseases in future. 
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6 Material and Methods 
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6.1 Animals 
 
Retinae of PN4 rhoEGFP (Chan et al. 2004) and PN0 nestin-EGFP mice (Yamaguchi et al. 
2000) were used as cell donors for microarray experiments. Transgenic rho-EGFP mice 
contained a knock-in of the human rhodopsin gene, fused to EGFP, resulting in green labeling 
of cell bodies in young rod photoreceptors and staining of the outer segment in mature cells 
(kind gift of John Wilson, Baylor College of Medicine, Houston, USA). In nestin-EGFP mice, 
retinal progenitor cells expressed EGFP, driven by regulatory elements of the nestin gene (kind 
gift of Masahiro Yamaguchi, Japan Science and Technology Corporation, Kyoto, Japan). The 
visualization of integrated photoreceptors after their transplantation was enabled with Nrl-EGFP 
mice, expressing EGFP under the control of the Nrl promoter (Akimoto et al. 2006) (kind gift of 
Anand Swaroop, National Eye Institute, Bethesda, MD, USA). Thus, all rods expressed EGFP 
and displayed green labeled synapses, cell bodies and inner segments. Additionally, 
transplantations conducted by my colleague Dominic Eberle, were performed with rhoEGFP 
mice, crossed with transgenic mice expressing DsRed driven by the ubiquitous chicken-actin 
promoter (actin-DsRed mice, strain B6.Cg-Tg(CAG-DsRed*MST)1Nagy/J; The Jackson 
Laboratory, Bar Harbor, ME, USA), called rhoEGFP/DsRed mice. As recipients, C57BL/6J wild-
type mice (purchased from Janvier, Le Genest-Saint-Isle, France) and Nrl-/- mice (Mears et al. 
2001) (kind gift of Anand Swaroop) were used. In Nrl-/- mice, the Nrl gene was deleted via 
homologous recombination, leading to the conversion of all rod photoreceptors into cone-like 
cells. 
L9021 MirTPH2 rats (kind gift of Michael Bader, Max-Delbrück-Centrum für molekulare Medizin, 
Berlin, Germany) and dark agouti rats (DA/HanRj; Janvier) were used for all rat experiments. 
L9021 MirTPH2 rats carried a construct coding for the ubiquitin promoter, driving a micro-RNA 
against CD8 and a GFP signal. CD8 is primarily expressed by cytotoxic t-lymphocytes and 
therefore, its down-regulation by micro-RNA against CD8 should not influence photoreceptors. 
GFP was expressed in a mosaic manner in the rat retina and thus allowed the visualization of 
transplanted cells. Dark agouti rats are pigmented wild-type animals and were used as 
transplantation recipients. 
All animals were treated in strict accordance with the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research and the European Union and German laws 
(Tierschutzgesetz). The animal ethics committee of the TU Dresden and the Landesdirektion 
Dresden approved all animal experiments (Az.: 24-9168.11-1/2012-33, 24-9168.11-1/2008-33, 
24-9168.24-1/2007-27).  
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6.2 Cell preparation, flow cytometry and RNA isolation  
Target cells were obtained and RNA was isolated following published methods (Eberle et al. 
2011; Eberle et al. 2012). In summary, eyes of cervical dislocated four-day-old rhoEGFP and 
newborn nestin-EGFP mice were collected and retinae were isolated in Hanks’ balanced salt 
solution (HBSS; Life Technologies, Darmstadt, Germany). Retinae were dissociated for 20 
minutes at 37 °C in HBSS, containing 0.5 mg/mL trypsin (Invitrogen, Karlsruhe, Germany). To 
stop digestion reaction, 2 mg/mL trypsin inhibitor (Roche Diagnostics, Mannheim, Germany) 
and 0.1 mg/mL DNase I (Invitrogen) were added. The cell solution was additional mechanical 
dissociated with 1 mL pipette and a fire-polished glass Pasteur pipette. After centrifugation (8 
min, 300 g), supernatant was removed and cells were resuspended in FACS buffer (HBSS, 5 % 
newborn calf serum [Invitrogen], 10 mM HEPES [PAA Laboratories, Pasching, Austria], 2 mM 
ethylenediaminetetraacetic acid [EDTA; Miltenyi Biotec, Bergisch Gladbach, Germany]) with a 
concentration of 1x107 cells/ml. Cells were sorted, based on their fluorescence, with FACSAria II 
(BD Bioscience, Heidelberg, Germany) and analyzed with FACS Diva software (BD Bioscience). 
Wild-type animals were used as control to gate for unspecific GFP auto-fluorescence. Life-dead 
discrimination was carried out using 0.1 µg/mL propidium iodate (Sigma-Aldrich, Munich, 
Germany) and additional doublet discrimination was performed to avoid contaminations with 
unwanted cells. RNA was isolated subsequently following instructions of RNeasy Mini Kit 
(Qiagen, Hilden, Germany). FACS plots were created using FlowJo V10 (TreeStar Inc., 
Ashland, OR, USA) and arranged with Adobe Illustrator (Adobe Systems Software, Dublin, 
Ireland). 
 
6.3 Microarray and data analysis 
 
Microarray experiment and data analysis were described previously (Eberle et al., 2011; Postel 
et al., 2013). In brief, RNA, isolated from three biological replicates of FAC-sorted PN4 
rhoEGFP photoreceptors, non-photoreceptors and PN0 nestin-EGFP retinal progenitors, was 
analyzed using mouse genome arrays (430 2.0 GeneChip; Affymetrix, Santa Clara, CA). 
Synthesizing of probes, hybridization, washing, and scanning of microarray chips were 
performed at the microarray facility of the Max Planck Institute of Molecular Cell Biology and 
Genetics (MPI-CBG, Dresden, Ger any) according to the  anufacturer’s instructions 
(Affymetrix). Analysis of data was performed using GeneSpring GX 11.0.1 software (Agilent 
Technologies). Normalization of chips was done with robust multiarray averaging algorithm. The 
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lower 20 % of entities were filtered out and ANOVA was applied to samples (p < 0.05), to 
identify entities that were significantly changed between the three conditions. The data were 
published (Eberle et al., 2011; Postel et al., 2013) and are available in NCBI´s GEO database 
(Edgar et al., 2002) with the GEO Series accession number GSE29318 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29318). Further analysis was carried 
out using DAVID  Huang et al ,    9)  Gene ontology ter  “to ological do ain: extracellular” 
was used to receive potential extracellular targets. The received list contained 65 entities 
(Suppl. table 1) that were screened with literature search using publicly available platforms, 
including pubmed (http://www.ncbi.nlm.nih.gov/pubmed), eurexpress 
(http://www.eurexpress.org/ee/), uniprot (http://www.uniprot.org/) and biogps 
(http://biogps.org/#goto=welcome). 
 
6.4 RNA isolation and RT-PCR for tissue distribution analysis 
 
Total RNA was isolated from the brain, heart, liver, kidney, spleen, lung, muscle, thymus, and 
retina of four-day-old mice with Qiagen RNeasy Mini Kit and QIAshredder following the 
manufacturer’s instructions (Qiagen). Subsequent cDNA synthesis was performed with 
SuperScript II reverse transcriptase (Life Technologies). Qiagen HotStarTaq Plus Mastermix Kit 
(Qiagen) was used for tissue-specific gene expression studies. Specific primers were designed 
using the Basic Local Alignment Search Tool from NCBI. Accession numbers and primer 
sequences used in each RT-PCR experiment are summarized in supplementary table 
2Supplementary table 2: Primer list. Succinate dehydrogenase complex, subunit A (SDHA) was 
used as housekeeping gene. 
 
6.5 Eye preparation and cryosectioning 
 
Retinae were collected and sectioned as described previously for ISH and 
immunohistochemistry (Eberle et al. 2011; Postel et al. 2013). Briefly, mice were sacrificed with 
cervical dislocation and rats with carbon dioxide, eyes were removed with curved forceps, a 
hole was punched into the cornea with a sharp 30-gauge needle (BD Bioscience) and eyes 
were incubated in 4 % paraformaldehyde at 4 °C (over night for ISH, 4 h for 
immunohistochemistry). Subsequently, eyes were dehydrated in 30 % sucrose (VWR, 
Darmstadt, Germany) in PBS over night. After removing of cornea and lens, the eyes were 
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embedded in tissue freezing medium (VWR), placed in a tank filled with 2-methyl-butane 
(VWR), and frozen in liquid nitrogen. Retinae were sectioned at 20 µm thickness with a Leica 
CM1900 cryotome (Leica Biosystems, Nussloch, Germany). 
 
6.6 Probe design and in situ hybridization 
 
Preparation of digoxigenin-labeled RNA probes and ISH-procedure were described previously 
(Postel et al. 2013). Following instructions of TA Cloning® Kit Dual Promoter (Life 
Technologies), genes of interest were cloned into pCR®II vector (Life Technologies). One 
Shot® TOP10 Escherichia coli were used for amplification of vectors. T7 and SP6 RNA 
polymerase (Roche, Grenzach-Wyhlen, Germany) were used for sense- or antisense RNA 
production with DIG RNA Labeling Mix (Roche Diagnostics) and subsequent purification of 
probes was carried out utilizing RNeasy® Mini Kit (Qiagen). 20x saline sodium citrate buffer 
(SSC), containing 175.3 g sodium chloride (Sigma-Aldrich), 88.2 g sodium citrate and 0.1 % 
diethylpyrocarbonate (DEPC; both AppliChem, Darmstadt, Germany), in 1 L deionized water 
was used to prepare 5x SSC (500 ml formamide [Sigma-Aldrich], 250 ml 20x SSC, 10 ml 10 % 
Tween® 20 pure [SERVA Electrophoresis GmbH, Heidelberg, Germany], 240 ml DEPC-H2O) 
and 2x SSC (200 ml formamide, 40 ml 20x SSC, 4 ml 10 % Tween® 20 pure, 156 ml DEPC-
H2O). Cryosections were incubated with anti-sense and control-sense RNA probes, diluted 
1:2,000 in pre-warmed hybridization buffer (25 % 20x SSC, 1 ml/L Tween® 20 pure, 50 % 
formamide, 1 mg/ml RNA from torula yeast type VI, 0.1 mg/ml Heparin, 2 % Denhardts solution 
50x [all Sigma-Aldrich], 1 ml/L CHAPS, 0.1 g/ml Dextran [all Carl Roth, Karlsruhe, Germany], 10 
mM EDTA [VWR]) overnight at 70 °C. Samples were washed 3 times for 1 h and 1 time over 
night in 5x SSC and additional 2 times for 1 h in 2x SSC. Slides were further washed in maleic 
acid buffer (100 mM maleic acid pH 7.5 with sodium hydroxide [both Sigma-Aldrich], 150 mM 
sodium chloride, 0.1 % Tween® 20 pure) and blocked for 1 h at room temperature in maleic 
acid buffer containing 1 % blocking reagent (Roche). Incubation with anti-digoxigenin antibody 
(1:5,000 in blocking solution; Roche Diagnostics) was performed over night at 4 °C. Further 
washing was performed 5x 10 min in maleic acid buffer and 2x in AP buffer (100 mM Tris pH 9.5 
[Carl Roth], 50 mM MgCl2 [VWR], 100 mM sodium chloride, 0.1 % Tween® 20 pure) at room 
temperature. Color development by incubation in BM Purple (Roche) was stopped with PBS, 
containing 5 mM EDTA, when a purple signal became visible. Sections were mounted on glass 
slides. 
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6.7 Cell isolation and MACS of mouse and rat photoreceptors 
 
For CD73-mediated MACS and subsequent transplantations, eyes of Nrl-EGFP or 
rhoEGFP/DsRed mice, L9021 MirTPH2 or DA/HanRj rats were removed from postnatal animals 
as described in chapter 6.2. After dissection, retinae were dissociated using Papain Dissociation 
System (Worthington Biochemical Corporation, Lakewood, NJ, USA) following manufactures 
instruction. Dissociated cells were enriched by MACS procedure as described before (Eberle et 
al. 2011). Briefly, up to 5x107 cells were resuspended in 0.5 mL MACS buffer containing PBS 
(pH 7.2), 0.5 % bovine serum albumin (BSA; Sigma-Aldrich), 2 mM EDTA (Miltenyi Biotec) and 
incubated with anti-CD73 antibody (for mouse cells: 10 µg/mL CD73 rat anti-mouse antibody, 
for rat cells: 5 µg/mL mouse anti-rat CD73 antibody [BD Phar ingen™, Franklin  akes, NJ, 
USA]) for 5 minutes at 4 °C. After washing in MACS buffer and centrifugation for 5 min at 300 g, 
the cell pellet was resuspended in MACS buffer containing secondary magnetic bead 
conjugated antibody (for mouse cells: goat anti-rat IgG magnetic beads, for rat cells: goat anti-
mouse IgG magnetic beads [80 µL buffer and 20 µL MicroBeads per 107 total cells; Miltenyi 
Biotec]). After 15 min incubation at 4 °C and a washing step with MACS buffer, cells were 
pelleted and resuspended in MACS buffer. Magnetic cell separation was performed following 
 anufacturer’s instructions  Miltenyi Biotec), using 30 µm pre-separation filters, LS columns and 
the MACS separator (all Miltenyi Biotec). Purified photoreceptor populations and photoreceptor-
depleted populations were collected by centrifugation and finally resuspended in MACS buffer, 
containing DNase I (0.1 mg/ml). 
Purity of unsorted, CD73-negative and CD73-positive sorted cell fractions was analyzed by flow 
cytometry (LSRII flow cytometer, FACS Diva software; both BD Bioscience), utilizing EGFP 
expression of photoreceptors (Nrl-EGFP or rhoEGFP mice) as well as labeling of CD73 
antibody on the surface of cells with APC-conjugated secondary donkey anti-rat IgG antibodies 
in mouse cells and donkey anti-mouse IgG antibodies (both eBioscience, Frankfurt, Germany) 
in rat cells. Cells, derived from wild-type retinae, served as negative controls to define the gates 
for separating EGFP-positive and -negative cells. For live/dead cell discrimination, populations 
were labeled with propidium iodide prior to flow cytometry analysis. 
Additional evaluation of CD73-dependent MACS of rat cells was performed with RT-PCR. RNA 
of CD73-positive, -negative and unsorted fractions was isolated, cDNA was produced and RT-
PCR was performed as described previously (chapter 6.4). Rat-primer: b-actin, forward: 
GTGTGATGGTGGGTATGGGTCAGAA, reverse: ACCAGAGGCATACAGGGACAACACA; 
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CD73, forward: CATGAACCTCCTGGGCTACG, reverse: CCACATGGATTCCACCCACT and 
rhodopsin, forward: ACCCTTGGAGGTGAAATCGG, reverse: GGGGTCTTGGTGGATGGATG. 
 
6.8 Transplantation 
 
Transplantations were performed as described previously (Eberle et al. 2011). In brief, the cell 
suspension containing MAC-sorted photoreceptors was transplanted into the subretinal space of 
adult C57BL/6J or Nrl-/- mice or DA/HanRj rats. Animals were anesthetized by an intraperitoneal 
injection of medetomidine hydrochloride (0.01 mg/10 g body weight for mice; 0.3 mg/kg body 
weight for rats; Dormitor; Pfizer, Berlin, Germany]) and ketamine (0.75 mg/10 g body weight for 
mice; 48 mg/kg body weight for rats; Ratiopharm, Ulm, Germany]). Tropicamide (1 %; Mydrum; 
Dr. Mann Pharma GmbH, Berlin, Germany) and phenylephrine (2.5 %; TU Dresden Pharmacy, 
Dresden, Germany) were used to dilate the pupils. For transplantation, animals were fixed in a 
head holder placed under a microscope. A syringe (Hamilton, Reno, NV, USA) containing a 
blunt, 34-gauge needle was inserted through the conjunctiva, sclera and retina into the 
subretinal space on the nasal part of the eye. One or two microliter MACS buffer were injected 
into mice or rats, respectively, containing 200,000 cells/µl. All transplantation experiments were 
performed by the same person. After transplantation, animals received an intraperitoneal 
injection of atipamezole hydrochloride (0.1 mg/10 g body weight for rats, 100 mg/kg body weight 
for rats; Antisedan; Pfizer) for reversal of medetomidine. 
 
6.9 Flat-mounting of retinae 
 
Two weeks after transplantation, eyes were collected and retinae were isolated as described 
above (chapter 6.5). The eyes were fixed in 4 % paraformaldehyde for 45 minutes, retinae were 
isolated and flat-mounted on the membrane of a 25 mm tissue culture insert (Sigma-Aldrich) 
and additionally incubated in 4 % paraformaldehyde at 4 °C for 45 min. Retinae were removed 
from membrane, transferred into a 24-well plate (VWR) and washed two times in PBS for 15 
minutes at room temperature. Subsequent staining was performed (chapter 6.10).  
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6.10 Staining of sectioned and flat-mounted retinae 
 
Cryoslides containing retinal sections (chapter 6.5) were air-dried for 1 h, rehydrated 30 min in 
PBS and blocked for 30 min in PBS containing 5 % goat serum (Sigma-Aldrich), 1 % BSA and 
0.3 % Triton X-100 (TU-Dresden Pharmacy). Staining with primary antibodies (Table 2A) was 
carried out overnight in PBS containing 1 % BSA. Excess of primary antibody was removed by 
washing 3 times, 10 min each, followed by incubating the sections with the respective 
secondary antibodies (Table 2B) in PBS containing 1 % BSA 1 h at room temperature. Samples 
were counterstained with 4', 6-diamidino-2-phenylindole (DAPI; 1:10,000; Sigma-Aldrich) and 
mounted on glass slides.  
Flat-mounted retinae (chapter 6.9) were incubated for 5 min in PBS, containing 5 % sodium 
dodecyl sulfate (SDS; SERVA). After washing (3 times) in PBS for 15 min, retinae were 
incubated in blocking solution (5 % fetal bovine serum [Sigma-Aldrich] and 0.3 % Triton X-100 in 
PBS) for 2 h at room temperature and subsequently incubated with primary antibodies (Table 2) 
in PBS containing 1 % FBS and 0.3 % Triton X-100 for 4 days at 4 °C. After 3 times washing on 
a shaker at room temperature in PBS, secondary antibodies (Table 2) in PBS with 1 % fetal 
bovine serum, 0.3 % Triton X-100 and DAPI (1:10,000) were added and retinae were incubated 
overnight at 4 °C. Finally, they were mounted on glass slides. 
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Table 2: Primary and secondary antibodies, used in immunohistochemisty 
A Primary antibodies 
  host antibody dilution company 
chicken GFP 1:500 Abcam, Cambridge, UK 
rabbit GFAP 1:500 DAKO, Hamburg, Germany 
rabbit PKCα  1:500 Santa Cruz, Heidelberg, Germany 
rabbit recoverin 1:5,000 Merck Millipore, Darmstadt, Germany 
mouse rhodopsin clone RET-P1 1:10,000 Sigma-Aldrich, Munich, Germany 
rabbit red/green opsin 1:5,000 Merck Millipore, Darmstadt, Germany 
rabbit Pcdh21 1:50 
kind gift of Amir Rattner, Johns Hopkins 
University, Baltimore, MD, USA 
mouse CD73 1:500 
BD Phar ingen™, Franklin  akes, NJ, 
USA 
    B Secondary antibodies 
  host antibody dilution company 
goat anti-chicken Dy488 1:1,000 Dianova, Hamburg, Germany 
goat anti-rabbit Cy3  1:1,000 Jackson ImmunoResearch, Suffolk, UK 
goat anti-mouse Cy5 1:1,000 Jackson ImmunoResearch, Suffolk, UK 
 
6.11 EdU labeling 
 
The thymidine analogue EdU (20 mM; Click-iT® EdU Imaging Kit; Invitrogen) was injected into 
female time-mated DA/HanRj rats 20 days after fertilization with a volume of 1µl/g body weight. 
After giving birth, additional EdU was injected into rat pups (5 mM, 4 µl/g body weight) at PN1 
and PN3. Retinal cells of stained pups were isolated at PN4, MAC-sorted and transplanted as 
described previously (chapter 6.7 and 6.8). Recipient animals were sacrificed, eyes were 
collected, fixed and sectioned (chapter 6.5). Prior to immunohistochemistry (chapter 6.10), 
detection protocol for EdU was applied following manufacturers instruction (Click-iT® EdU 
Imaging Kit; Invitrogen) using Alexa Fluor® azide (Alexa 647) for visualization. 
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6.12 Quantification, image processing and statistics 
 
Photoreceptors were considered as integrated when the cell body was localized in the ONL and 
an extension towards either the subretinal space or the OPL was observed. For quantification, 
serial sections were counted using fluorescence microscopy (Z1-Imager with ApoTome; Carl 
Zeiss Meditec, Jena, Germany). Bright field and fluorescence images for figures were taken with 
the same fluorescence microscope and gel images for RT-PCR were taken with the QUANTUM 
gel documentation system model 1100 (PEQLAB Biotechnology, Erlangen, Germany). All 
images were processed with ImageJ (National Institutes of Health, Bethesda, USA), Adobe 
Photoshop and Adobe Illustrator (Adobe Systems Software). For quantification of area covered 
by transplanted cells, flat-mounted retinae were imaged with a 2.5x objective. Single images 
were stitched together using ImageJ plugin MosaicJ (Thévenaz and Unser 2007). Area of 
coverage is shown as percentage from the ratio between area covered by cells and whole 
retinal area.  
Statistics for quantifications of integrated cells and for FACS data were calculated with MS 
Excel (Microsoft Corporation, Redmond, USA). The data are presented as mean ± SEM from at 
least three independent biological replicates. Significance was calculated by unpaired, two-
tailed, Student’s t-test and ANOVA with Tukey’s correction for  ulti le co  arison, when 
indicated, and is represented in figures by *p<0.05, **p<0.01 and ***p<0.001. 
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8.1 Supplementary table 1: DAVID-enriched gene list 
 
Probe Set ID Gene Symbol Gene Title Entrez 
1450770_at 3632451O06Rik 
RIKEN cDNA 3632451O06 gene = 
Uncharacterized protein C14orf37 homolog 
67419 
1454632_at 6330442E10Rik RIKEN cDNA 6330442E10 gene = Tmem229b 268567 
1439983_a_at Accn3 amiloride-sensitive cation channel 3 171209 
1418128_at Adcy6 adenylate cyclase 6 11512 
1456388_at Atp11a ATPase, class VI, type 11A 50770 
1460294_at, 
1440627_at 
Atp8a2 
ATPase, aminophospholipid transporter-like, 
class I, type 8A, member 2 
50769 
1423812_s_at, 
1451127_at 
AW146242 expressed sequence AW146242 232023 
1435541_at Btc 
betacellulin, epidermal growth factor family 
member 
12223 
1449955_at Cacna1f 
calcium channel, voltage-dependent, alpha 1F 
subunit 
54652 
1457703_at, 
1441084_at 
Cacna2d4 
calcium channel, voltage-dependent, alpha 
2/delta subunit 4 
319734 
1439048_at, 
1429211_at 
Cadm2 cell adhesion molecule 2 239857 
1419206_at Cd37 CD37 antigen 12493 
1427401_at, 
1442035_at 
Chrna5 cholinergic receptor, nicotinic, alpha polypeptide 5 110835 
1457008_at Chrnb4 cholinergic receptor, nicotinic, beta polypeptide 4 108015 
1448393_at Cldn7 claudin 7 53624 
1445085_at, 
1421860_at 
Clstn1 calsyntenin 1 65945 
1451763_at Cnga1 cyclic nucleotide gated channel alpha 1 12788 
1450492_at Cngb3 cyclic nucleotide gated channel beta 3 30952 
1418799_a_at Col17a1 collagen, type XVII, alpha 1 12821 
1441330_at Crb1 crumbs homolog 1 (Drosophila) 170788 
1430110_at D230044M03Rik RIKEN cDNA D230044M03 gene 76743 
1436209_at Dnajc16 DnaJ (Hsp40) homolog, subfamily C, member 16 214063 
1442101_at Elfn1 
leucine rich repeat and fibronectin type III, 
extracellular 1 
243312 
1419171_at Fam174a family with sequence similarity 174, member A 67698 
1421841_at Fgfr3 fibroblast growth factor receptor 3 14184 
1422193_at Gucy2e guanylate cyclase 2e 14919 
1422645_at, 
1450702_at 
Hfe hemochromatosis 15216 
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1419647_a_at Ier3 immediate early response 3 15937 
1455158_at, 
1421997_s_at, 
1460305_at 
Itga3 integrin alpha 3 16400 
1434070_at, 
1421106_at 
Jag1 jagged 1 16449 
1425107_a_at, 
1454984_at, 
1450207_at 
Lifr leukemia inhibitory factor receptor 16880 
1426288_at Lrp4 low density lipoprotein receptor-related protein 4 228357 
1435393_at Mc1r melanocortin 1 receptor 17199 
1424534_at, 
1438654_x_at 
Mmd2 
monocyte to macrophage differentiation-
associated 2 
75104 
1456068_at, 
1459357_at 
Nfasc neurofascin 269116 
1444317_at, 
1421503_at, 
1442326_at 
Pcdh15 protocadherin 15 11994 
1418304_at Pcdh21 protocadherin 21 170677 
1450144_at Pla2r1 phospholipase A2 receptor 1 18779 
1448688_at Podxl podocalyxin-like 27205 
1419700_a_at Prom1 prominin 1 19126 
1422832_at Rgr retinal G protein coupled receptor 57811 
1440256_at Rgs9bp regulator of G-protein signalling 9 binding protein 243923 
1425172_at, 
1451617_at, 
1425171_at, 
1451618_at 
Rho rhodopsin 212541 
1420885_a_at, 
1427674_a_at 
Sez6 seizure related gene 6 20370 
1423852_at, 
1423851_a_at 
Shisa2 shisa homolog 2 (Xenopus laevis) 219134 
1416986_a_at, 
1416985_at, 
1448534_at 
Sirpa signal-regulatory protein alpha 19261 
1420361_at Slc11a1 
solute carrier family 11 (proton-coupled divalent 
metal ion transporters), member 1 
18173 
1428986_at Slc17a7 
solute carrier family 17 (sodium-dependent 
inorganic phosphate cotransporter), member 7 
72961 
1460386_a_at, 
1448299_at, 
1425415_a_at 
Slc1a1 
solute carrier family 1 (neuronal/epithelial high 
affinity glutamate transporter, system Xag), 
member 1 
20510 
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1456971_at Slc1a7 
solute carrier family 1 (glutamate transporter), 
member 7 
242607 
1436865_at Slc26a11 solute carrier family 26, member 11 268512 
1436164_at Slc30a1 
solute carrier family 30 (zinc transporter), member 
1 
22782 
1460129_at, 
1421641_at 
Slc6a2 
solute carrier family 6 (neurotransmitter 
transporter, noradrenalin), member 2 
20538 
1434559_at, 
1426151_a_at, 
1425530_a_at, 
1425536_at 
Stx3 syntaxin 3 20908 
1426511_at Susd2 sushi domain containing 2 71733 
1428975_at, 
1453648_at 
Susd3 sushi domain containing 3 66329 
1434800_at Sv2b synaptic vesicle glycoprotein 2 b 64176 
1418345_at 
Tnfsf12 /// 
Tnfsf12-tnfsf13 
/// Tnfsf13 
tumor necrosis factor (ligand) superfamily, 
member 12 /// tumor necrosis factor (ligand) 
superfamily, member 12-member 13 /// tumor 
necrosis factor (ligand) superfamily, member 13 
21944 
/// 
619441 
/// 
69583 
1422924_at Tnfsf9 
tumor necrosis factor (ligand) superfamily, 
member 9 
21950 
1417577_at Trpc3 
transient receptor potential cation channel, 
subfamily C, member 3 
22065 
1455642_a_at Tspan17 tetraspanin 17 74257 
1445972_at, 
1431750_at 
Ush2a 
Usher syndrome 2A (autosomal recessive, mild) 
homolog (human) 
22283 
1427894_at, 
1455812_x_at 
Vasn vasorin 246154 
1423551_at, 
1434115_at 
Cdh13 cadherin 13 12554 
1440537_at Kcnv2 potassium channel, subfamily V, member 2 240595 
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8.2 Supplementary table 2: Primer list 
 
Accession 
Number 
Gene Forward  ri er  5′ to 3′) Reverse  ri er  5′ to 3′) 
Amplicon 
length (bp) 
NM_026142.4 3632451O06Rik AACAAAGCCACCACATGGGA CCAGCTTCTCACCAGACCTT 1069 
NM_178745.4 6330442E10Rik GACTGTGATAAGAGGTCCCAGT GAAACACCACCGAACACACG 1218 
NM_007405.2 Adcy6 TTGGCGCCAGCCAAAAACGG AGCCAAGCCATGGACGCCAA 968 
NM_015804.3 Atp11a TGACAGCTTGCACGCCACGA ATCCAAGCCTCTGCACGCCT 953 
NM_015803.2 Atp8a2 TCAACGAAGAGCTGGGGCAGGT ATGGCCGCCCTTGTTGCATCT 985 
NM_007568.5  Btc TGCACAGGTACCACCCCTAGACA GCACATCAGCTTTGACTCTGGGTCC 1100 
NM_001033382.2 Cacna2d4 TGCCACTGGACAAAGGGAAGCG TTCGGCCGCACTGTGGTGAT 995 
NM_178721.4  Cadm2 AAAGTCAAAGGCAGCCAAGGGCA AGCATGGTCAGGGCCATTCTGG 933 
NM_019707.4  Cdh13 TGCGTCCTGCTGTCCCAGGT CAGCAGCGCAGGTGACACCA 924 
NM_007723.2 Cnga1 AACATCCTCCCCTGCCAATGCCAT GCAGATCGGTCGGTATCACTGACA 994 
NM_172338.2  Dnajc16 TTGGGCGTGTCCTGGCGATT TTGGGCGTGTCCTGGCGATT 1011 
NM_013565.2 Itga3 TGCGCATGAGGCATTGCTCACCCT ACGGCCACAAGCACCAACCACA 993 
NM_183179.1 Kcnv2 TTTGCACGCAGCGCCCTCAA AGCTCCTGGTGTGACGCTCCAT 1061 
NM_172668.3  Lrp4 AACGCAACTGCACCACCTCCA TCAGCAATGATGCGACGCCCA 997 
NM_130878.2  Pcdh21 TCCGCGGAGACATGAGGCGT GGCATTGGCTCCCTGGTCTGAG 1193 
NM_023281.1 Sdha ATGCTGTGGTTGTAGGCGCT TTCCCCAGAGCAGCATTGAT 151 
NM_025491.3  Susd3 AATGGGAGCACCGTTGACTGGT TCCAGCTGGGCAAACGTTGACT 623 
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